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ABSTRACT 
OXYGEN TOXICITY AND MITOCHONDRIAL METABOLISM 
Jian Li 
November 14, 2003 
Oxygen is critical to aerobic metabolism, but hyperoxia is cytostatic and 
cytocidal. The precise mechanisms involved in hyperoxic cell injury remain incompletely 
understood although there is substantial support for the possibility that hyperoxia 
increases the 'leak' of electrons from the mitochondrial electron transport chain and the 
resulting increased generation of reactive oxygen species (ROS) might explain the toxic 
effects of high oxygen. To evaluate the possible role of mitochondria in oxygen toxicity, 
we used cloned HeLa cells having no functional mitochondria (ρ° cells) as a model. In 
contrast to wild-type HeLa cells, ρ° cells survive and grow in 80% O2 but are equally 
susceptible to oxidant-mediated killing. Two other strategies which diminish 
mitochondrial ROS generation (exposure of cultures to either carbonyl cyanide m-
chlorophenylhydrazone [CCCP] or chloramphenicol) also increase tolerance of wild-type 
HeLa cells to hyperoxia. Thus, three different maneuvers which minimize mitochondrial 
ROS production improve cell survival and growth under hyperoxia. This suggests that 
mitochondrial ROS production is primarily responsible for hyperoxic damage. Results of 
experiments with an oxygen tolerant strain of HeLa cells, which proliferates even under 
80% O2, termed 'HeLa-80', lend further support to this general concept. In this oxygen 
tolerant cell line, antioxidant defenses are similar to the parent line of HeLa cells. In 
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addition, these two cell lines are equally susceptible to killing by hydrogen peroxide and 
t-butyl hydroperoxide. However, under both 20% and 80% O2, intracellular ROS 
production is >2-fold higher in HeLa-20 cells compared to HeLa-80 cells as assessed by 
(1) dihydrodicholorfluorescein oxidation, (2) dihydroethidium oxidation, (3) hyperoxia-
mediated suppression of aconitase activity and (4) mitochondrial protein carbonyl 
content. Diminished ROS production may be related to the fact that the oxygen-tolerant 
HeLa-80 cells have significantly higher cytochrome c oxidase (COX) activity (~ 2.0 fold) 
than HeLa-20, and preferential blockade of this terminal complex of mitchondrial 
electron transport by treatment with n-methyl protoporphyrin, which selectively 
diminishes synthesis of heme-aa3 in COX, abrogates the tolerance of HeLa-80 cells to 
hyperoxia and increases ROS production in HeLa-80 cells under hyperoxia. In the 
oxygen tolerant HeLa cells, the elevated COX activity may be due to a >2-fold increase 
in COX Vb (a regulatory subunit of COX) whereas expression levels of three other COX 
subunits (COX I, II and IV) are very close to wild-type. Finally, preliminary results 
indicate a similar over-expression of COX activity in a unique strain of oxygen tolerant 
rats. Overall, our results suggest that it is possible to make cells tolerant of hyperoxia 
either by depletion of electron-rich intermediates (in the oxygen tolerant HeLa cells or 
wild-type cells treated with CCCP) or by blockade of respiration (rho° and 
chloramphenicol-treated cells). These observations may serve to guide new 
pharmaceutical strategies to diminish tissue damage in patients exposed to hyperoxia and 
to lessen the mitochondrial production of cytotoxic ROS by cellular mitochondria in 
other clinical situations.  
 vi
TABLE OF CONTENTS 
                  PAGE 
ACKNOWLEDGEMENTS………………………………………………………...iii 
ABSTRACT………………………………………………………………...............iv 
LIST OF TABLES………………………………………………………………….xi 
LIST OF FIGURES………………………………………………………………...xii 
 
INTRODUCTION 
Brief History of Oxygen…………………………………………….......................1 
Therapeutic Applications of Oxygen: Success with Toxic Side-Effects…………..2 
An Unexpected Toxicity of Hyperoxia: the Tragedy of Retrolental Fibroplasia.....2 
Early Reports of Oxygen Toxicity and the Basis of Oxygen Toxicity…………….3 
Theories Regarding the Mechanism of Oxygen Toxicity………………………….4 
Oxygen Tolerance………………………………………………………………….6 
Oxygen Tolerance In Eukaryotic Cells…………………………………………….7 
ROS and Oxygen Toxicity…………………………………………………………9 
Mitochondrial Electron Transport…………………………………………………10 
What is the Source of Increased ROS Generation During Hyperoxic Exposure?...11 




Metabolic Control of Respiration by COX………………………………………....19 
COX Activity is Selectively Inhibited by Heme Deficiency……………………….20 
Summary…………………………………………………………………………....21 
MATERIALS AND METHODS 
Cell Culture………………………………………………………………………... 23 
Establishment of ρ° Cells…………………………………………………………...28 
Preparation of ρ° Cybrids…………………………………………………………...29 
Peroxide-Mediated Cytotoxicity…………………………………………………....30 
Estimation of Reactive Oxygen Species (ROS) Production………………………..31 
Measurement of Aconitase Activity………………………………………………..33 
Estimation of Mitochondrial Protein Carbonyls…………………………………....34 
Determination of the Source of Intracellular ROS Generation…………………… .35 
Determinations of O2 Consumption, Glucose Utilization and Lactate Production under 
both Normoxic and Hyperoxic Conditions…………………………………………38 
Assays of the Activities of Respiratory Chain Components………………………..39 
Preparation of Purified Mitochondria from Fresh Rat Liver……………………….43 
Preparation of Mitochondria from Cultured Cells………………………………….44 
Enzymatic Detection of the Lysosomal Marker Enzyme, β-Galactosidase………...45 
JC-1 Staining as an Indicator of Mitochondrial Membrane Potential –     
Microscopy…………………………………………………………………………......46 
JC-1 Accumulation as an Indicator of Mitochondrial Membrane Potential – 
Spectroscopy……………………………………………………………………………46 
Measurement of Heme Oxygenase Enzyme Activity…………………………….....46 
 viii
Electrophoretic Procedures and Western Blotting…………………………………47 
Real-Time Reverse Transcript Polymerase Chain Reaction (RT-PCR)…………...52 
Small Interference RNA (SiRNA) Transfection…………………………………...55 
RESULTS AND DISCUSSION       
Part I. ROS Produced by Mitochondria are Causally Related to Hyperoxic Cell 
Damage………………………………………………………………………………..59 
 A. ρ° cells have a growth and survival advantage in hyperoxia…………………..60 
 B. ρ° cybrids exhibit wild-type sensitivity to hyperoxia………………………….65 
 C. ρ° cells are not resistant to oxidant killing……………………………………..68 
 D. Differences in intracellular ROS generation in wild-type vs. ρo cells………....70 
 E. Pharmacologic suppression of mitochondrial ROS production also permits the 
survival and growth of wild-type HeLa cells under hyperoxia…………………....73 
 F. Summary of Part I……………………………………………………………...79  
Part II:  Investigations of a Unique Line of Oxygen-Tolerant HeLa Cells…………...81 
A. HeLa-80 cells grow and survive in hyperoxia………………………………....81 
B. HeLa-20 and HeLa-80 cells do not differ in susceptibility to oxidant killing…88 
C. Oxygen tolerant HeLa-80 cells exhibit decreased ROS production under both 
normoxia and hyperoxia…………………………………………………………..92 
D. Additional evidence that oxygen tolerant HeLa-80 cells generate less ROS under 
both normoxia and hyperoxia……………………………………………………..97 
E. Mitochondrial respiration inhibitors modulate ROS production by both HeLa-20 
and HeLa-80cells…………………………...…………………………………....100 
F. Summary of Part II……………………………………………………………104 
 ix
Part III: Why Do the Mitochondria in HeLa-80 Cells Generate ROS?.......................105 
A. HeLa-80 cells are more metabolically efficient ………………………………105 
B. Cytochrome c oxidase (COX) activity is elevated in HeLa-80 cells………….110 
C. There are no corresponding differences in the activities of complexes I-III in HeLa-
20 vs. HeLa-80 cells………………………………...……………………………113 
D. Preferential inhibition of cytochrome c oxidase activity in HeLa-80 cells abrogates 
their oxygen tolerance……...……………………………………………………..117 
E. HeLa-80 cells show a highly significant increase in ‘respiratory potential’…..123 
F. Summary of part III…………………………………………………………....125 
Part IV. Molecular Basis for the Increased COX Activity in HeLa-80 Cells……….126 
A. Subunit Vb of COX is over-expressed in HeLa-80 cells……………………...127 
B. COX Vb mRNA levels are similar in HeLa-20 and HeLa-80 cells…………...129 
C. Suppression of COX Vb expression via Small - interference RNA (SiRNA) in 
HeLa-80 cells……...……………………………………………………………...131 
D. Summary of Part IV…………………………………………………………...134 
Part V: Oxygen Tolerant Rats and HeLa-80 Cells: A Common Mechanism?............135 
A. Background…………………………………………………………………....135 
B. Pulmonary fibroblasts from oxygen tolerant rats are more sensitive to peroxide-
mediated killing………………………………………………………...………...136 
C. In the oxygen tolerant rats, mitochondrial COX activity is amplified………...138 
DISCUSSION………………………………………………………………………..140 
The Cytostatic and Cytocidal Effects of Hyperoxia are Associated with Enhanced 
Intracellular ROS Production……………………………………………………..143 
 x
The Origins of Hyperoxia-Mediated ROS Generation……………………………144 
The Importance of Antioxidant Status in Oxygen Toxicity……………………….145 
Oxygen Tolerant HeLa Cells Have Normal Antioxidant Defenses……………….147 
Mitochondrial Metabolism is the Focal Point of Hyperoxic Cell Injury………….148 
Cytochrome c Oxidase (COX) and ROS Production……………………………...149 
The Possibility That Increased COX Vb Expression Plays A Major Role in Higher 
COX Activity of HeLa-80 Cells………………………………………………......151 
Oxygen Tolerance in HeLa Cells and Rats: A Common Mechanism?...................152 
The Possibility That Oxygen Tolerance Arises from Enhanced Anti-Apoptotic 
Mechanisms………………………………………………………………………154 
Do Hyperoxia and Radiation Damage Cells through A Common Mechanism?....155 








LIST OF TABLES 
 
TABLE                 PAGE 
1. Cell lines employed and their characteristics……………………………………….25 
2. Sense and antisense primers used for quantitative RT-PCR analysis………………58 
3. Cytochrome c oxidase activity and O2 consumption in wild-type and respiration-
deficient HeLa cells…………………………………………………………………...62 
4. Adenine nucleotide related intermediates in HeLa cells………………………….109
 xii
LIST OF FIGURES 
 
FIGURE                 PAGE 
1. Study model: oxygen tolerant HeLa-80 cells………………………………………..8 
2. Mitochondrial electron transport chain…………………………………………….12 
3. The Q cycle………………………………………………………………………...16 
4. Mitochondrial electron transport and sites of action of various inhibitors………...37 
5. Growth characteristics of wild-type and ρo HeLa cells in normoxic and hyperoxic 
conditions…………………………………………………………………………….63 
6. Growth characteristics of ρo HeLa cells and cybrids in hyperoxic conditions……66 
7. Mitochondrial ROS generation in wild-type, ρo and cybrid HeLa cells…………..67 
8. Susceptibility of wild-type, ρo and cybrid HeLa cells to oxidant-mediated cell   
death………………………………………………………………………………….69 
9. Wild-type, but not ρo, HeLa cells show hyperoxia-dependent inhibition of aconitase 
activity………………………………………………………………………………..71 
10. Wild-type, but not ρo, HeLa cells show hyperoxia-dependent increased mitochondrial 
protein carbonyl formation…………………………………………………………...72 
11. The protonophoric uncoupler, CCCP, decreases ROS production and enhances the 
survival of HeLa cells under hyperoxia……………………………………………....74 
 xiii
12. Inhibition of mitochondrial protein synthesis with chloramphenicol decreases ROS 
production and increases survival of HeLa cells under hyperoxia…………………...77 
13.  Growth characteristics of wild-type HeLa-20 and oxygen tolerant HeLa-80 cells in 
normoxic and hyperoxic conditions…………………………………………………..83 
14. Changes in mitochondrial membrane potential (reflected by JC-1 staining) in the 
absence and presence of 10 µM CCCP………………………………………………86 
15. HeLa-20 and HeLa-80 cells were grown under 80% Oxygen for 10 days……….87 
16. Total heme oxygenase activities measured in HeLa-20, HeLa-80 and rhoo HeLa-20 
cell lines………………………………………………………………………………89 
17. Bcl-2 levels in HeLa-20, HeLa-80, rho0-HeLa20 and the corresponding 
cybrids………………………………………………………………...........................90 
18. Susceptibility of wild-type HeLa-20 and oxygen tolerant HeLa-80 cells to oxidant-
mediated cell death…………………………………………………………………...91 
19. Mitochondrial ROS generation in wild-type HeLa-20 and oxygen tolerant HeLa-80 
cells…………………………………………………………………………………...93 
20. Mitochondrial ROS generation in wild-type HeLa-20 and oxygen tolerant HeLa-80 
cells under both normoxic and hyperoxic conditions………………………………...95 
21. Wild-type HeLa-20, but not oxygen tolerant HeLa-80 cells, show hyperoxia-
dependent inhibition of aconitase activity……………………………………………98 
22. Wild-type HeLa-20, but not oxygen tolerant HeLa-80 cells, show hyperoxia-
dependent increased mitochondrial protein carbonyl formation……………………..99 
 
 xiv
23. Inhibitors of complexes I and II decrease ROS production in both HeLa-20 and 
HeLa-80 cells…………………………………………………………………………101 
24. The mitochondrial inhibitor, antimycin A, increases ROS production in both HeLa-20 
and HeLa-80 cells……………………………………………………………………103 
25. Glucose consumption by HeLa cells were measured over a 24-hr period under both 
normoxic and hyperoxic conditions………………………………………………….106 
26. Lactate production by HeLa cells over a 24-hr period under both normoxic and 
hyperoxic conditions ………………………………………………………………...107 
27. Cytochrome c oxidase activity in HeLa-20 and HeLa-80 cells………………….111 
28. Complex I (NADH reductase) activity in HeLa-20 and HeLa-80 cells………….114 
29. Complex II (succinate reductase) activity in HeLa-20 and HeLa-80 cells………115 
30. Complex III (cytochrome c reductase) activity in HeLa-20 and HeLa-80 cells…116 
31. N-methyl protoporphyrin (NMP) preferentially blocks COX activity…………...118 
32. N-methyl protoporphyrin (NMP) preferentially decreases COX subunit II……...119 
33. ROS production by HeLa-80 cells grown in the continuous presence of 5 µM N-
methyl protoporphyrin (NMP) for different periods………………………………….121 
34. COX suppression abrogates the oxygen tolerance of HeLa-80 cells……………..122 
35. Oxygen consumption by HeLa-20 and HeLa-80 cells in the absence and presence of 
20 µM CCCP………………………………………………………………………….124 
36. Western blot analysis of COX subunit expression in HeLa-20 and HeLa-80 cells.128 
37. Similar mRNA levels of COX Vb in HeLa-20 and HeLa-80 cells detected by real 
time RT-PCR…………………………………………………………………………..130   
 xv
38. Significantly decreased COX Vb proteins in siRNA transfected HeLa-80 cells by 
Western blot…………………………………………………………………………...132 
39. Significantly decreased mRNA level for COX Vb in siRNA transfected HeLa-80 
cells as detected by real time RT-PCR……………………………………..................133 
40. Primary pulmonary fibroblasts cultured from oxygen tolerant rats are more sensitive 
to peroxide-mediated killing…………………………………………………………..137 
41. Hepatic mitochondrial COX activity in control and oxygen tolerant rats………...139 
42.  Schematic representation of our tentative conclusions…………………………...142 
 
 xvi





Brief History of Oxygen 
Centuries ago, it was known that air was composed of more than one component. 
The behavior of oxygen and nitrogen as components of air led to the advancement of the 
phlogiston theory of combustion, which tortured chemists for a century. Oxygen was 
produced by several chemists prior to its 'formal' discovery in 1774 by Joseph Priestley 
and Carl Wilhelm Scheele. Both produced oxygen by heating mercuric oxide (HgO), 
generating 'dephlogisticated air' (Priestly) or 'fire air' (Scheele). Antoine Lavoisier, who 
coined the term 'oxygen' from ‘oxus’ (gr. acid) and ‘gennan’ (gr. generate) did so out of 
the mistaken impression that this substance was required for the formation of all acids.  
 
Oxygen, a diatomic gas (O2) at standard temperature and pressure, makes up 
approximately 21% of the earth's atmosphere. Oxygen is both highly reactive (able to 
combine with most elements) and required for respiration, the major source of metabolic 
energy for most aerobic organisms. Unfortunately, as reviewed below, prolonged 
exposure to pure oxygen can be toxic, having both pulmonary and (when administered 
hyperbarically) neurological effects. Pulmonary effects include edema, loss of lung 
capacity and damage to lung tissues. More acute neurological effects of exposure to very 
high oxygen pressures include loss of vision, convulsions and coma.  
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Therapeutic Applications of Oxygen: Success with Toxic Side-Effects 
Oxygen supplementation is certainly not a new concept as a therapeutic modality 
for treating the sick. The use of hyperbaric air began in 1662 when Henshaw, a European 
physician, used it to treat respiratory ailments and to ‘cool the fires of the heart'. After the 
discovery of oxygen in 1774, air was enriched with oxygen and even more benefits were 
claimed, all unfounded. At the end of the 1800’s, Paul Bert discovered that oxygen was 
poisonous at high pressure. Despite this, interest in the medical use of hyperoxia and 
hyperbaric air persisted and, in 1918, Orval Cunningham, an American physician, was 
very successful in the treatment of pneumonia by hyperbaric air. Around this time, Dr. 
Edgar End also obtained good results in treatment of victims of carbon monoxide 
poisoning with hyperbaric oxygen therapy. Following two decades of relative inactivity 
in research on hyperoxia/hyperbaria, Boerema and Brummelkamp, two American 
surgeons, in the late 1950’s, used a hyperbaric oxygen chamber during cardiovascular 
surgery and for the therapy of gas gangrene. This marked the beginning of the modern era 
of hyperbaric oxygen therapy. However, as reviewed below, this was not without major 
mishap. 
 
Unexpected Toxicity of Hyperoxia: the Tragedy of Retrolental Fibroplasia 
Around 1940, hyperoxia came to be used extensively to support respiratory 
function, especially in newborn infants with pulmonary insufficiency. Shortly thereafter, 
the first description of retrolental fibroplasia (RLF) was published in 1942. Over the next 
decade, thousands of babies became blind before the outbreak of this previously rare 
disease was firmly attributed to the use of supplemental oxygen. The first suggestion that 
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oxygen might cause retrolental fibroplasia was made by Kate Campbell (Campbell, 1951) 
and the first controlled trial suggesting that too much oxygen could damage the eyes of 
preterm babies appeared in 1952 (Patz et al., 1952). In that year, the first large landmark 
trial in neonatal medicine confirmed that although oxygen was a ‘good thing’ it was quite 
possible to have ‘too much of a good thing’ (Kinsey et al., 1956). In further support of 
this, it was found that preterm infants receiving 70% oxygen for 4-7 weeks frequently 
developed RLF whereas those receiving <40% oxygen for 1-2 weeks were spared the 
disease (Patz et al., 1952; Crosse and Evans, 1952). About this time realization dawned 
that high oxygen might affect the lung as well as the eye (Carpenter et al., 1973).  
 
Early Reports of Oxygen Toxicity and the Basis of Oxygen Toxicity 
A general precept of toxicology is that anything is toxic at a high enough 
concentration (Paracelsus, 1493-1541). Without question, this is true of oxygen (Knight, 
1998). Oxygen has often been referred to as ‘a double-edged sword’; although it is 
critical for life, many essential intracellular reactions which require oxygen result in the 
formation of free radicals.  
 
Shortly after the discovery of oxygen, Lavosier reported that oxygen inhalation 
had poisonous effects (Binger et al., 1927). Oxygen toxicity was first described in 
laboratory animals by Bert in 1878 who found that high concentrations of oxygen caused 
convulsions and death in sparrows, some laboratory animals, insects and even 
earthworms. Twenty years later, Smith showed that increased oxygen tensions cause 
severe pulmonary congestion with pneumonia-like changes in mice, rats and guinea pigs 
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(Smith et al., 1899). Later, in 1927, Binger also reported that concentrations greater than 
70% oxygen were poisonous to dogs, rabbits, guinea pigs, and mice (Binger et al., 1927). 
In 1945, Comoroe and colleagues reported the toxic effects of inhalation of high 
concentrations of oxygen in normal men both at sea level and at a simulated altitude of 
18,000 feet above sea level (Comoroe et al., 1945).  
 
Despite the above evidence of pulmonary oxygen toxicity and the clear example 
of RLF, it was not until the mid 1960's that lung damage from hyperoxia was definitely 
recognized. Nash (Nash et al., 1967) reported a close relationship between the 
concentration and duration of inspired oxygen before death and pulmonary pathologies at 
autopsy. One year later, the formation of pulmonary hyaline membranes in adults was 
reported to result from treatment with hyperoxia (Soloway et al., 1968). These and many 
other observations left no doubt that, especially with regard to the lung, hyperoxia was 
“too much of a good thing”. 
 
Theories Regarding the Mechanism of Oxygen Toxicity 
Although the first experiment regarding a free radical reaction was reported in 
1894 (Fenton et al., 1894), the involvement of free radicals (or, more properly, reactive 
oxygen species) in oxygen toxicity was not suspected until Gerchman proposed that 
damage caused by both hyperoxia and X-irradiation might have a common basis - the 
formation of free radicals (Gerschman, 1954). Indeed, oxygen and gamma radiation exert 
synergistic effects; in the presence of oxygen, the dose of gamma irradiation needed to 
kill cells is about one-third of the dose needed for an equal effect under anoxic conditions 
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(the so-called 'oxygen enhancement ratio') (Alper and Howard-Flanders, 1956; Dewey, 
1960). This probably is because only about one-third of the damage caused by x-
irradiation is due to a direct hit on DNA whilst the remainder of the damage arises from 
the production of reactive oxygen species (which then secondarily damage DNA). 
 
Despite the early and prescient suggestion by Gerschman that oxygen toxicity 
might have a free radical basis, the importance of free radicals in biological systems was 
not generally accepted until the discovery of superoxide dismutase in 1969 (McCord and 
Fridovich, 1969). Free radicals are now widely considered to be very important in many 
(perhaps too many) pathological processes such as aging, atherosclerosis, cancer, cardiac 
myopathy, cataractogenesis, diabetes mellitus, immune system disorders, 
ischemia/reperfusion injury, liver diseases, kidney diseases, lung diseases, 
neurodegenerative disorders, nutritional deficiencies, radiation injury and skin disorders 
(Knight, 1998). This list definitely includes hyperoxic injury to cells and organs which 
clearly involves reactive oxygen production promoted by hyperoxia (Jamieson, 1989). 
 
The present (albeit vague) theory of oxygen toxicity is that during hyperoxic 
exposure reactive species (ROS) are produced at a rate which exceeds the detoxification 
capacity of cellular antioxidant defenses (Jamieson, 1989). The amount of hyperoxia 
required to cause cellular damage and the time course of these changes vary from species 
to species and from individual to individual within the same species. Age, nutritional 
status, presence of underlying diseases, and certain drugs may influence the development 
of oxygen toxicity. There is currently no reliably effective drug for preventing or 
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delaying the development of oxygen toxicity in humans but, as described below, 
instances of oxygen tolerance have been described.  
 
Oxygen Tolerance 
Some evidence for the involvement of ROS in hyperoxic damage derives from 
studies of oxygen tolerant animals. For example, a number of earlier investigations 
clearly show that very young animals are more tolerant to hyperoxia than are their older 
counterparts (Clark and Lamberts, 1971), yet the age-dependent factor(s) involved in this 
tolerance remain unknown. Furthermore,  it has been known for many years that 
tolerance to hyperoxia can be induced in some species, mainly rats, by various means 
such as intermittent exposure to hyperoxia or prior exposure to raised but sublethal 
concentrations of oxygen (Clark and Lamberts, 1971). Interestingly, similar tolerizing 
effects have been demonstrated using injections of endotoxin or cytokines such as IL-1 
and tumor necrosis factor-alpha (TNF-α) (Frank and Roberts, 1978b; 1978a; Frank et al., 
1978; Tsan et al., 1991a; 1991b; 1991c; 1992a; 1992b). The protective effects of these 
pre-treatment regimens have been ascribed variously to the induction of particular 
antioxidant enzymes (e.g., Mn-SOD), changes in nitric oxide production, diminished 
neutrophil recruitment and modulation of alveolar macrophage activity (Capellier et al., 
1998a; 1998b) . For example, following bacterial endotoxin pre-treatment, adult rats 
exposed to 95-98% O2 demonstrated increased activities of pulmonary SOD, catalase and 
glutathione peroxidase (Frank and Roberts, 1978b). We should note, however, that, 
although increases in antioxidant enzyme activities have been correlated with increased 
oxygen tolerance, the responses associated with tolerance have been cell type- and animal 
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species-dependent (Deneke and Fanburg, 1980; Deneke and Fanburg, 1982), suggesting 
that each particular cell system may have its own characteristic survival strategy to 
oxygen stress (Gille et al., 1988). Nonetheless, these earlier findings raised the concept 
that increased or over-expressed antioxidant activity might confer oxygen tolerance.  
 
Oxygen Tolerance In Eukaryotic Cells 
Interestingly, cultured cells also can be used as in vitro models of oxygen toxicity 
and tolerance. An oxygen-tolerant line of HeLa cells was previously developed by Dr. 
Hans Joenje (Joenje et al., 1985) by continuous culture of wild-type cells with stepwise 
increases of pO2 over a prolonged period of time (approximately 21 months). The 
selection process is shown in Figure 1. These HeLa cells (termed 'HeLa-80') can survive 
and proliferate under 80% O2, an oxygen concentration that is lethal to the original cell 
line and most other cell types. Importantly, this oxygen tolerance is a stable genetic 
characteristic. Long-term culture of HeLa-80 cells under normoxic conditions does not 
affect tolerance to subsequent exposure to hyperoxia. This selection for genetic variant(s) 
was probably aided by the notorious genetic instability of HeLa cells. HeLa cells are 
genetically heterogeneous (McCord, 1969) and this heterogeneity may be enhanced under 






























Despite many decades of work on the question, it is still not known how 
hyperoxia causes damage to cells and tissues. Nonetheless, it is commonly believed that 
free radicals play a key role in the pathophysiology of oxygen toxicity and cellular 
damage is probably mediated by increased production of ROS (Gerschman et al., 1954). 
This excessive production of ROS likely derives from the mitochondria which, under 
conditions of high oxygen, exhibit increased electron leak from the electron transport 
chain (Chance et al., 1979; Gerschman et al., 1954). 
 
Based on the free radical theory of oxygen toxicity, it might be anticipated that 
physiologic mechanisms of this unusual oxygen tolerance might arise from (1) decreased 
intracellular generation of ROS, (2) increased levels of antioxidant defense enzymes, (3) 
an increased repair/turnover rate of damaged cell components, or (4) some combination 
of these. A major goal of the present research was to attempt to dissect these possibilities.  
 
ROS and Oxygen Toxicity 
If enhanced ROS production is, in fact, at the root of oxygen toxicity, then there 
are at least two major ways in which cells might avoid oxygen toxicity: hypertrophied 
antioxidant defense systems or lesser production of ROS. Important antioxidant defenses 
include glutathione and related enzymes (glutathione reductase, glutathione peroxidase, 
thioredoxin/thioredoxin reductase, peroxiredoxins), ascorbic acid, vitamin E, catalase, 
superoxide dismutases (both the cytoplasmic Cu/Zn SOD and the mitochondrial Mn 
SOD), and control of intracellular transition metals by proteins such as metallothionine 
and ferritin (Scott et al, 1997). However, in the case of the oxygen tolerant HeLa cells 
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under study, it appears that the activities of all defenses against ROS measured thus far 
are normal (i.e., nearly identical to those in the wild-type Hela-20 cells) (Joenje et al., 
1985e). This has two major implications. First, it indicates that the tolerance of these cells 
to high oxygen is probably not due to hypertrophied defenses against ROS. Second, many 
of these antioxidant enzymes are known to be induced by ROS. The fact that these 
enzymes display normal activities even in HeLa-80 cells exposed to high oxygen 
suggests that these cells somehow manage to avoid exaggerated ROS production even 
when exposed to high partial pressures of oxygen (Joenje et al., 1985d; Gille et al., 1988). 
 
Mitochondrial Electron Transport 
The apparent lack of any changes in antioxidant defenses in the HeLa-80 cells 
directed our attention to the mitochondrial electron transport chain (Figure 2). Reducing 
species such as NADH and FADH2 are generated in the cytosol from glycolysis and in 
the mitochondrial matrix from the tricarboxylic acid cycle. Mitochondria generate ATP 
from reduced electron carriers via oxidative phosphorylation. The energy carried by the 
reduced electron carriers is released gradually by passing electrons along the components 
of the electron transport chain and is used to create a proton gradient across the inner 
mitochondrial membrane. The electron transport chain consists of four inner membrane-
associated complexes, ubiquinone and cytochrome c. Complex I (ubiquinone 
oxidoreductase) accepts electrons from NADH and transfers them to ubiquinone.  
Ubiquinone also can accept electrons from complex II and other FADH2 containing 
dehydrogenases.  Electrons are further transferred from reduced ubiquinone to complex 
III, then to cytochrome c, complex IV (COX) and finally to molecular O2 (which is fully 
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reduced to H2O).  The proton gradient created by the electrons passing through 
complexes I, III and IV is used to power ATP synthase (complex V).  
 
What is the Source of Increased ROS Generation During Hyperoxic Exposure? 
Energy production by mitochondria is essential for a multitude of cellular functions, 
including intermediary metabolism, ion regulation and other active transport processes, 
cell mobility and cell proliferation. In most cells, the vast majority of energy (about 95%) 
is derived from oxidative phosphorylation. But even under well-coupled (normoxic) 
conditions, as much as 1-2% of the reducing equivalents escape the respiratory chain, 
initially as superoxide (O2-) and, thence, hydrogen peroxide (H2O2) (Chance et al., 1979). 
In vivo, particularly in tissues not exposed to atmospheric oxygen, the proportion of 
oxygen converted O2- is likely to be smaller since the intramichondrial pO2 is between 3 
and 30 µM (Genova et al., 2001; Alvarez et al., 2003). Because ROS generation is a 
continuous process, mitochondria and extra-mitochondrial compartments possess 
efficient antioxidant systems (as described above). Under hyperoxic conditions, or in the 
presence of defective antioxidant systems (as might, for example, be the case for 













Figure 2. Mitochondrial electron transport chain.  
Note the formation of ubisemiquinone (Q.) between complexes II and III, thought 
by many investigators to be the major source of superoxide formation. 
 
   
  
   
O2.-
      
O2
 
   
ATP  
   
 ADP+Pi 
  
 H + 




















































   synthase 
  
  13
ROS have been implicated in cell dysfunction and death associated with 
hyperoxia (Hengartner, 2000). It is likely that metabolically-generated ROS (primarily 
O2- and H2O2) are not particularly injurious because H2O2 reacts slowly with most targets 
and O2-, although capable of inactivating certain enzymes (especially those with iron-
sulfur clusters in the active site), is actually a reducing agent. The dismutation of O2- 
occurs in stages; O2- must first combine with a proton to yield the hydroperoxyl radical, 
HO2 , which is more reactive than O2- (Bielski, 1979). Formation of HO2 is favored at pH 
values lower than "physiological", but the phagocytic vacuole operates at an acid pH and 
the pericellular pH of macrophages has been reported to be 6 or less (Etherington, 1979). 
Although HO2 can act as a direct oxidant, the majority of damage from metabolic ROS 
may involve radical generation catalyzed by transition metals such as iron and copper. In 
the presence of O2- and H2O2, these metals can produce the dread, highly-reactive 
hydroxyl radical (HO.) via Fenton-type chemistry or, in the case of iron, related 
ferryl/perferryl species.  
 
Even under normal conditions, ROS are important agents of cell damage and, in 
extremis, apoptotic and necrotic cell death. Exogenously added ROS such as H2O2 and 
tert-butyl hydroperoxide induce either form of cell death depending on concentration 
(Brunk et al., 2001; Antunes et al., 2001). Furthermore, quinone compounds such as 
menadione can undergo redox cycling, leading to the production of excessive amounts of 
O2- and H2O2, which will cause cell death (Gutierrez et al., 1982). Even in the absence of 
such xenobiotics, increased endogenous ROS production has been implicated in the 
etiology of a great many neurodegenerative disorders (such as Alzheimer's disease, 
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Down's syndrome, and familial amyotrophic lateral sclerosis), inflammatory and 
cardiovascular diseases (Amstad et al., 2001). 
 
Where is the Site of ROS Formation in Mitochondria? 
Assuming that hyperoxic cell damage does arise from exaggerated mitochondrial 
ROS production, the site of electron leak from the electron transport chain becomes an 
important question. Although this is still an area of some controversy, most experts agree 
that ubisemiquinone, present at both complex I and complex III, is a likely candidate. 
Several studies have reported that complex III is the main site of ROS production under 
normal metabolic conditions, especially in heart and lung mitochondria (Finkel et al., 
2000; Goijman et al., 1985; Turrens et al., 1982; Turrens, 1997; Turrens, 2003). 
Ubiquinones are very hydrophobic (bearing usually 6 to 10 isoprene units) and can 
undergo both one- and two-electron reduction. The one-electron reduction intermediate 
(just like that formed in the case of menadione mentioned above) is called 
ubisemiquinone. The fully reduced (2e-) form is called ubiquinol or dihydroubiquinone. 
 
Q Cycle 
In the so-called Q cycle, electrons from ubiquinol are donated to complex III, one 
electron reducing an iron-sulfur (FeS) protein and the second reducing cytochrome b. The 
FeS protein is a lower-energy carrier, while cytochrome b is a higher energy carrier, able 
to pass electrons back to ubiquinone (forming ubisemiquinone). Also, in this process, 
protons are relocated; ubiquinol passes the electrons to the FeS protein and cytochrome b, 
translocating two protons. One of the electrons (the one on the FeS protein) is passed on 
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to cytochrome c and down the electron transport chain. Thus, for each electron from 
complex I, two protons are translocated (Figure 3) (Birch-Machin et al., 2001). 
 
The redox-cycling of quinones has been used in cancer therapy. Some quinone-
containing anti-tumor agents are enzymatically reduced leading to the formation of either 
the (ROS-generating) semiquinone or the hydroquinone. The semiquinone can donate its 
extra electron to O2 with the formation of O2- and the original quinone. In contrast, the 
two-electron reduced hydroquinone is usually stable and may be excreted or otherwise 
detoxified without causing secondary damage. However, in some cases, such as aziridine 
quinones, the hydroquinone can be oxidized one electron at a time, resulting in the 
production of O2-, the semiquinone and the parental quinone. So, in brief summary, redox 
cycling xenobiotics can kill cells by effecting the one electron reduction of oxygen to O2- 
in reactions which probably involve transition metal-catalyzed production of highly 
reactive ROS such as HO.. These reactions probably explain some of the anti-cancer 
effects of redox-cycling quinones although the semiquinone intermediate also may be 


















Figure 3. The Q cycle. In the Q cycle, ubisemiquinone (Q˙-) is associated with complex 
III, the electron donor for superoxide formation in a reaction, presumably dependent on 
the partial pressure of oxygen.  
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Overall, semiquinones are the dangerous species whereas two-electron reduced 
products such as ubiquinol can have antioxidant effects, interrupting O2--initiated chain 
reactions and lipid peroxidation. In the particular case of mitochondria and ubiquinone, 
inhibition of complex III by antimycin A in isolated liver mitochondria results in the 
accumulation of ubisemiquinone with greatly increased O2- production (Zhang et al., 
2001). As mentioned above, one way in which cells might avoid damage from 
spontaneously generated ROS (whether under normal or high O2 conditions) might 
involve diminished production of these species by mitochondrial ubisemiquinone. 
However, how could cells manage to have lower steady-state concentrations of 
ubisemiquinone and still survive? In fact, there is an example from Caenorhabditis 
elegans. In this ~900 cell worm, a mutant (clk) has been found which is associated with 
increased longevity and impaired synthesis of coenzyme Q10. Replenishment of normal 
coenzyme Q10 levels leads to decreased longevity, probably associated with increased 
leak of electrons from the electron transport chain (Branicky et al., 2000; Wong et al., 
1995). 
   
Cytochrome c Oxidase 
In the results reported below, cytochrome c oxidase (COX) is an important factor 
in the explanation of why HeLa-80 cells have an oxygen-tolerant phenotype. COX is the 
terminal enzyme of the mitochondrial electron transport chain, which consists of four 
complexes (I-IV), all in the inner membrane of the mitochondria. Complex I 
(NADH:ubiquinone oxidoreductase) and complex II (succinate:ubiquinone 
oxidoreductase) oxidize mitochondrial NADH and succinate, respectively, to form 
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ubiquinol. Ubiquinol is then oxidized to ubiquinone by complex III 
(ubiquinol:cytochrome c oxidoreductase), which reduces cytochrome c. Cytochrome c 
then delivers electrons to complex IV, COX. It catalyzes the reduction of dioxygen (O2) 
to water and indirectly harnesses the free energy of the reaction to phosphorylate ADP to 
ATP. COX consists of 13 subunits in mammalian cells. The three catalytic subunits, 
COX I, II and III, are coded by the mitochondrial DNA and are synthesized within 
mitochondria. Heme a, heme a3 and Cub are ligated to subunit I, while Cua is ligated to 
subunit II which is also the binding site for cytochrome c (Regan et al., 1998; Yoshikawa, 
1999).The remaining 10 subunits of the mammalian enzyme, namely, IV, Va, Vb, VIa, 
VIb, VIc, VIIa, VIIb, VIIc and VIII, are encoded by the nuclear genome, synthesized in 
the cytosol and imported into mitochondria (Capaldi, 1990; Taanman, 1997; 
Vijayasarathy et al., 1998). Some of the nuclear-encoded subunits in mammals are 
regulated developmentally and occur as tissue specific isoforms (Bonne et al., 1993; 
Taanman et al., 1993). Although the nuclear-encoded COX subunits, such as COX IV, 
Vb, VIa and VIb, have been shown to enhance the catalytic efficiency of the enzyme 
(Anthony et al., 1993; Weishaupt and Kadenbach, 1992), the precise role of many 
nuclear-encoded subunits in the mammalian enzyme complex remains unknown. 
 
The function of COX is closely linked to both oxygen availability and heme, a 
prosthetic group. It has been shown that both oxygen and heme act as physiological 
modulators and regulate the expression of the enzyme complex in yeast (Poyton and 
Dagsgaard, 2000). COX subunit V is expressed as two distinct isoforms, Va and Vb, 
which are regulated by heme and O2 in yeast (Burke and Poyton, 1998). In mammalian 
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systems, however, the differential expression of nuclear-encoded subunits in response to 
different physiological factors has not been investigated in detail. 
 
Metabolic Control of Respiration by COX 
As reviewed by Kadenbach and Arnold (1999), the first mechanism of respiratory 
control is based on the mitochondrial proton motive force, ∆p (Bell et al., 1992), which is 
generally assumed to represent the energy-rich intermediate of oxidative phosphorylation. 
However, in eukaryotes, ∆p is not the only parameter controlling the rate of respiration. 
A second mechanism of respiratory control-intramitochondrial ATP/ADP ratio-via 
binding of the nucleotides to subunit IV of COX (Steenaart and Shore, 1997), contributes 
to maintainance of a constant and relatively low mitochondrial membrane potential, ∆ψ 
(the major component of ∆p). The second mechanism of respiratory control requires that 
COX plays the rate limiting step in mitochondrial respiration. Whether COX is the rate 
limiting step of cell respiration, although COX catalyzes the only irreversible reaction 
(O2 Æ H2O) in the respiratory chain has been debated. Some old publications reported 
that COX capacity was 5-7 fold in excess of that required to support the endogenous 
respiration of isolated mitochondria (Letellier et al., 1993; Letellier et al., 1994; Wanders 
et al., 1981). However, under these experimental conditions, there was a significant 
alteration of the environment due to the possible loss of essential metabolites and to the 
absence of cytosolic substrates and coenzymes when the metabolic control analysis was 
carried out in the isolated mitochondria instead of the intact cells.  
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Recently, studies of the metabolic control of respiration in intact cells revealed a 
tight control of cell respiration by COX, exceeding its capacity above the endogenous 
respiratory activity only by 7-25% (Villani et al., 1998; Villani and Attardi, 1997). 
Erecinska and Wilson also came to similar conclusions. They proposed that an 
equilibrium exists between the reactions of NADH oxidation and cytochrome c reduction 
in mitochondria, but that COX represents an irreversible and rate-limiting reaction 
(Erecinska and Wilson, 1982). Kadenbach proposed that the different control strength of 
COX measured in isolated mitochondria vs. intact cells might be due to uncoupling of the 
second mechanism of respiratory control during isolation of mitochondria (Kadenbach 
and Arnold, 1999). 
 
The metabolic control of respiration by COX is important to maintain a 
physiological low mitochondrial ∆ψ of 100-130 mV in vivo (Wan et al., 1993). The 
control of respiration by ∆p alone would allow ∆ψ to rise to very high levels, around 160-
220mV (Hafner and Brand, 1988). High ∆ψ values will have adverse consequences, 
including increased O2- formation. (Boveris and Chance, 1973; Korshunov et al., 1997; 
Liu, 1997) .  
 
COX Activity is Selectively Inhibited by Heme Deficiency 
When administered to mice, certain inhibitors of heme biosynthesis (e.g., succinyl 
acetone and cobalt chloride) can cause a 50% reduction in mitochondrial genome-
encoded COX I and II mRNAs and nuclear genome encoded COX Vb mRNA 
(Vijayasarathy et al., 1999). Important to the present investigations, heme deficiency, 
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relatively selective for the type of heme in a subunit of COX also can be induced by n-
methyl protoporphyrin (NMP), selectively interrupting the assembly of COX (Atamna et 
al., 2001). Some studies suggested that heme deficiency might regulate not only 
mammalian COX gene expression but also catalytic activity of the enzyme by affecting 
its stability or composition (Vijayasarathy et al., 2003). 
 
Heme deficiency occurs in iron deficiency (Ackrell et al., 1984), in porphyria 
patients and with advanced age (Bitar and Shapiro, 1987; Scotto et al., 1983), especially 
under conditions of stress (Freedman, 1987). This may be because the activity of 
ferrochelatase, which catalyzes metallation of protoporphyrin IX at the terminal step of 
heme biosynthesis, declines in the livers of old rats, as does COX activity (Boffoli et al., 
1994). Similar, but perhaps more marked, changes also are observed in Alzheimer's 
disease patients (Ojaimi et al., 1999a; 1999b). 
 
Summary 
As reviewed above, despite decades of work the nature of hyperoxic damage to 
cells remains incompletely understood. So also are the mechanisms by which cells might 
achieve an oxygen tolerant state. With this latter in mind, we elected to proceed with 
investigations of the oxygen tolerant HeLa-80 cell line previously established by Dr. 
Hans Joenje. We hoped that these cells might yield valuable clues as to the nature of 
hyperoxic damage and ways in which this damage might be avoided. As reported below, 
we have generated nearly conclusive evidence that the majority of hyperoxic cell damage 
derives from enhanced mitochondrial ROS formation. Furthermore, successful adaption 
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to hyperoxia - at least from the example of the HeLa 80 cells - would appear to depend on 
changes which limit mitochondrial ROS generation rather than enhancement of cellular 
antioxidant defenses. Overall, we believe that knowledge of the mechanism(s) permitting 
these cells to be tolerant of hyperoxia may be extremely valuable - not only for 
understanding the nature of oxygen damage itself but also to the understanding of basic 
cellular oxidative stress and antioxidant balance which are critical in many disease 
processes. Furthermore, the results of these investigations may be helpful in the future 






MATERIALS AND METHODS 
 
Cell Culture 
Cells and reagents: 
A wild-type strain of HeLa-20 cells (which grow under 20% oxygen) and an 
oxygen tolerant strain of HeLa-80 cells (which can grow under 80% oxygen) were 
generously provided by Dr. Hans Joenje (Institute of Human Genetics, Free University, 
Amsterdam, The Netherlands.). Carbonyl cyanide m-chlorophenylhydrazone (CCCP), 
ethidium bromide (EB), bovine heart cytochrome c, chloramphenicol, guanidine, 
bilirubin, porcine heart isocitrate dehydrogenase, sodium citrate, β-NADH, MnCl2, 2,4-
dinitrophenylhydrazine (DNP), trichloroacetic acid (TCA), sucrose, potassium phosphate, 
ethylenediaminetetraacetic acid (EDTA), tris (hydroxymethyl)aminomethane 
hydrochloride (Tris-HCl), ethyl acetate and streptomycin sulfate were purchased from 
Sigma Chemical Co. (St. Louis, MO). N-methyl protoporphyrin (NMP) and heme were 
from Porphyrin Products (Logan UT). Heparin was obtained from Bristol-Myers Squibb 
Company (Princeton, NJ). Dulbecco’s Modified Eagle’s Medium (DMEM), Ham’s F-10 
medium, phosphate buffered saline (PBS), HEPES, glutamine, penicillin, trypsin-EDTA 
and some lots of FBS were obtained from GIBCO LifeTechnologies (Grand Island, NY). 
Dihydrodicholorfluorescein (DCF) and dihydroethidium were purchased from Molecular 
Probes (Eugene, OR). Percoll was from Amersham Pharmacia Biotech. Polyethylene 
  24
glycol 2000 (PEG) was obtained from Fluka (Milwaukee, WI). For ρo HeLa:platelet 
fusions (see below), a 45% PEG solution (w/v) was prepared at 65°C in Hanks’ balanced 
salt solution (HBSS), subsequently sterilized by 0.22 µm Millipore filtration and held at 




Cell type Characteristics Culture medium 
HeLa-20 wild-type HeLa cells DMEM 
HeLa-80 oxygen-tolerant HeLa cells DMEM 
ρ° HeLa-20 HeLa cells lacking mtDNA 
Enriched DMEM (4 
mg/ml glucose, 100 µg/ml 
pyruvate and 50 µg/ml 
uridine) 
ρ° HeLa-20  
cybrids 





Table 1. Cell lines employed and their characteristics. 
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General conditions of cell culture: 
HeLa cells were routinely cultured in DMEM supplemented with 1 mM 
glutamine and 10% (v/v) heat-inactivated FBS under 20% O2 (normoxia) or 80% O2 
(hyperoxia) with 5% CO2 at 37°C. For routine passage, cells were washed with PBS and 
lifted with 0.05% trypsin, 0.02% EDTA in PBS. Stock cultures were grown in 
polystyrene T-75 culture flasks in a Forma Scientific incubator under an atmosphere of 
20% O2, 5% CO2.  Exposure to hyperoxia was performed with cells grown in 10-cm 
dishes under an atmosphere of 80% O2, 15% N2 and 5% CO2 contained in a specially 
designed gas-tight modular incubator chamber (Billups-Rothenberg, Inc., CA). The 
sealed chamber was placed in a standard tissue culture incubator and the gas was 
replenished every 48 hr. Because the respiration-deficient ρo cells require special 
supplements to the medium, all test cells were cultured in ‘enriched DMEM’ (see below) 
under both normoxic and hyperoxic conditions. The survival and growth of cells were 
assessed over a period of 10 days by counting cell numbers in marked sectors of the 
culture dishes using light microscopy.  
 
It is important to note that the oxygen tolerance of HeLa-80 cells is a stable 
characteristic. Even after these cells have been continuously passed in normoxic culture 
for more than two months they retain their resistance to 80% O2 when re-exposed. 
However, being aware that the characteristics of cultured cells can ‘drift’ under 
conditions of continuous culture, we prepared >70 stabilates of each cell line, stored in 
liquid nitrogen. In the experiments reported here, cultures were replenished from these 
stabilates every 30 days and the oxygen tolerance of each new culture was checked. 
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Cell culture in the presence of CCCP and chloramphenicol: 
As an alternative way of suppressing mitochondrial respiration and ROS 
production, HeLa cells (initial density ~5 x 104 per 10 cm dish) were treated with 1 µM 
CCCP or 50 µg/ml chloramphenicol. CCCP, a protonophoric uncoupler of oxidative 
phosphorylation, causes a loss of mitochondrial membrane potential (Kessler, 1976), 
increases respiration and, paradoxically, decreases ROS production. Chloramphenicol 
selectively inhibits mitochondrial protein synthesis (Deanin, 1973) and decreases both 
respiration and mitochondrial ROS generation. Cells were cultured in CCCP or 
chloramphenicol under 20% O2 for 2 days prior to exposure to 80% O2 and control 
cultures were carried out under 20% O2 to detect possible drug effects on cell growth. 
 
Cell culture in the presence of n-methyl protoporphyrin (NMP): 
At appropriate concentrations, the porphyrin derivative, NMP, selectively 
decreases the activity of COX (Atamna et al., 2001) through partial inhibition of 
ferrochelatase (Gamble et al., 2000; Tangeras, 1986). HeLa cells (initial density ~5 x 104 
per 10 -cm dish) were treated with 5 µM NMP for 9 days under both normoxia and 
hyperoxia. The medium was changed every 4 days. A previous study using this dose of 
NMP to inhibit ferrochelatase showed that the enzymatic activity decreases to ~15% of 
control (Tangeras, 1986). Ferrochelatase, the terminal enzyme in the heme biosynthetic 
pathway, catalyzes the insertion of iron (II) into protoporphyrin IX. Twelve hours after 
plating, the cells were treated with NMP in complete medium under normoxic conditions 
for 24 hr prior to exposure to 80% O2. Control cultures were maintained under 20% O2 to 
detect possible drug effects on cell growth. 
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Establishment of ρ° Cells 
To deplete wild-type HeLa cells of mitochondrial DNA (mtDNA), cells were 
cultured in the presence of 400 ng/ml EB for 8 months. For this, the standard DMEM 
medium was supplemented with 4 mg/ml glucose, 100 µg/ml pyruvate and 50 µg/ml 
uridine (‘enriched DMEM’) to compensate for (1) respiratory incompetence, (2) pyridine 
nucleotide redox imbalance and (3) pyrimidine/purine auxotrophy arising from 
mitochondrial dysfunction. ρo clones were isolated using limiting dilution cloning and 
grown for at least 3 weeks in enriched DMEM in the absence of EB to ensure stable ρo 
status. The ρo state was assured by (i) estimation of mitochondrial membrane potential 
(JC-1 staining), (ii) absent 200 bp PCR product for mtDNA, (iii) low-absent O2 
consumption and (iv) deficient COX activity. For estimation of mitochondrial membrane 
potential, JC-1 was added to the cell culture for 30 min at 37°C, at a final concentration 
of 5 µM. The cells were then washed 3 times in HBSS and examined by fluorescence 
microscopy. In order to estimate residual mtDNA, total DNA was isolated from cells 
using a DNA isolation kit (QIAGEN Inc., Valencia, CA) according to the manufacturer’s 
instructions. PCR was performed using mtDNA primers (sense - 
CCCCACAAACCCCATTACTAAACCCA; antisense - 
TTTCATCATGCGGAGATGTTGGA TGG) (Ayala-Torres et al., 2000). The 200 bp 
PCR product was resolved by 0.8% agarose gel electrophoresis and the EB-stained DNA 
was quantified using a Molecular Dynamics Image System (Molecular Dynamics, 




Preparation of ρ° Cybrids 
Obtaining platelets from human blood:  
In order to re-introduce functional mitochondria into HeLa ρo cells, 20 ml of 
heparinized venous blood was obtained from a healthy volunteer. The platelets were 
isolated by differential centrifugation as described by Mann et al. (Mann et al., 1992).  
The following procedures were performed at room temperature, unless otherwise 
specified and manipulations were carried out in a sterile hood, using sterile reagents and 
pipettes. The volume of blood was determined and the blood was transferred to a sterile 
50-ml screw-capped polypropylene tube, and one-ninth volume of 0.1 M sodium citrate 
and 0.15 M NaCl were added. The cell suspension was mixed by inversion and 
centrifuged the at 200 xg for 20 min at 4°C. The platelet-rich plasma was collected, 
leaving behind at least 3 mm of plasma above the red blood cell layer to avoid 
erythrocyte contamination. The platelet concentration in the plasma was determined at 
this point by counting in a hemocytometer in a phase-contrast microscope. The platelet-
rich plasma was then centrifuged in a sterile 15 -ml polypropylene tube at 1500 xg for 20 
min at 4°C and the pellet containing the platelets was suspended in about 2 ml 
physiological saline. Following trituration using a small bore pipette, physiological saline 
was added to a final volume of 11 ml.  
 
Preparation of reconstituted cybrids of transformed ρo HeLa cells: 
For restoration of functional mitochondria, fusion of normal human platelets with 
ρo HeLa lines was performed by a modification (Higuchi et al., 1997) of the method of 
Chomyn et al. (Chomyn et al., 1994). The platelet suspension, prepared as described 
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above (containing <1% of other cell types), was centrifuged for 30 min at 2,000 xg at 
4°C. The pellet was resuspended in 10 ml PBS and centrifuged for 15 min at 1,500 xg at 
4°C. 1 x 107 washed platelets were added to a 2 ml suspension of ρo HeLa cells (5 x 105 
in DMEM). The mixed cells were sedimented by centrifugation at 180 xg for 10 min at 
room temperature. Following aspiration of the supernatant, 0.1 ml of a PEG solution 
(45% w/v PEG 2000 in HBSS) was added and the cells were gently resuspended. After 1 
min incubation at 37°C, 10 ml of enriched DMEM was added slowly, the cells were 
centrifuged for 5 min at 150 xg, suspended in 2 ml enriched DMEM and cultured for 5-
7 days. The medium was then changed to selective medium (regular DMEM with 10% 
FBS but lacking supplemental glucose, uridine and pyruvate) which only permits the 
growth of cells containing functional mitochondria. Three weeks later, subcloning was 
performed by limiting dilution and tests for mitochondrial function were conducted as 
described above.  
 
Peroxide-Mediated Cytotoxicity 
To determine whether changes in mitochondrial function might have secondary 
effects on cellular resistance to exogenous oxidants, the cytotoxic effects of both H2O2 
and t-butyl hydroperoxide were measured. For these experiments, HeLa-20 and HeLa-80 
cells, ρo HeLa cells and cybrids were grown in 48-well plates (initial density ~2 x 104 
cells per well in 0.5 ml of enriched DMEM) for three days. When cells were 90% 
confluent, the medium was replaced with 1.0 ml of HBSS and the cells were exposed to 
the indicated concentrations of H2O2 or t-butyl hydroperoxide for 2 hr at 37°C. HBSS 
was used for these tests to avoid the confounding effect of varying contamination of FBS 
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with catalase. The HBSS was then replaced with enriched DMEM. Following 10 hr 
culture under normal conditions (20% O2/5% CO2 at 37°C), Alamar Blue was added and, 
after a 4 hr incubation, fluorescence of the reduced dye was measured at ex530 nm and 
em590 nm (Nikolaychik et al., 1996; Nociari et al., 1998; Page et al., 1993) using a 
spectrofluorometric plate reader (Molecular Devices Corp., Sunnyvale, CA). Cell 
viability was calculated as the ratio of surviving cells to the original cell population.  
 
Estimation of Reactive Oxygen Species (ROS) Production 
The generation of ROS was evaluated under atmospheres of both 20% and 80% 
O2. The tests under normoxic conditions assessed the oxidation of two probes: DCF-DA 
(added to cells bathed in Hanks’ balanced salt solution (HBSS) and dihydroethidium 
(cells in complete culture medium). Two distinct probes were employed to ensure that the 
same proportionate differences were evident. The more long-term incubations of cells 
under hyperoxic conditions required that we use dihydroethidium exclusively because 
cells are not viable long-term in HBSS and because some time is needed for full 
equilibration of the cells with the atmospheric oxygen levels (~3 hr; Stevens, 1992).  
 
For a number of reasons, we believe that DCF-DA is an optimal probe for short-
term measurements of steady-state intracellular ROS generation (Amstad et al., 2001). 
Other probes such as dihydrorhodamine were not used because they report on two 
processes: the initial oxidation of the probe and the subsequent concentration of the 
oxidized product (rhodamine) by the mitochondria. Inasmuch as we had reason to think 
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that these cells might differ in mitochondrial function and membrane potential, the use of 
such a probe would have been inappropriate. 
 
The non-fluorescent DCF-DA precursor enters cells by passive diffusion 
whereupon the two acetate groups are esterolytically cleaved. Within the cell, the probe 
can be oxidized in a reaction which requires H2O2 and a peroxidase or pseudoperoxidase 
such as cytochrome c or redox-active Fe. Upon oxidation, the probe is converted to 
highly fluorescent 2',7'-dichlorofluorescin (DCF). Although DCF, once formed, can 
diffuse out of the cell, in our conditions the medium is not changed and therefore, all of 
the DCF formed is measured. To assess ROS production with this probe, cells were 
plated onto 48-well plates at an initial density of 2x104 cells per well. After cells were 
>90% confluent, they were washed 3 times with HBSS or/and treated with various 
inhibitors of respiration in 0.5 ml HBSS for 5 min. Following the addition of 10 µM 
DCF-DA (final concentration), the appearance of DCF fluorescence was followed 
continuously using a heated plate reading spectroflurometer (Molecular Devices Corp., 
Sunnyvale, CA), typically for 1 hr, with product detection at ex486 nm and em530 nm. 
Following the experiment, cell protein was measured in each well using the bicinchoninic 
acid reaction (Smith et al., 1985) (Pierce, Rockford, IL) and the relative fluorescence was 
corrected for variations in cell protein between wells.  
 
Alternatively, the generation of ROS was evaluated under both 20% O2 and 80% 
O2 using the oxidation of dihydroethidium (Bindokas et al., 1996). Cells were plated onto 
48-well plates at an initial density of 2x104 cells per well. When cells were >90% 
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confluent, 3-4 days later, fresh medium containing 100 µM dihydroethidium with or 
without 10 µM of the protonophoric uncoupler, CCCP, was added. ROS generation was 
estimated after 4 hr incubation with dihydroethidium under 20% or 80% O2. In 
comparison with DCF-DA, dihydrotethidium permits estimates of ROS formation over 
longer periods of time in complete culture medium and the product, ethidium, is held 
within the cell via intercalation into DNA. We should note, however, that the latter event 
is eventually toxic to cells, limiting experiments to a maximum of 8 hr. After incubation 
with dihydroethidium, cells were washed 3 times with HBSS and ethidium fluorescence 
was detected at ex520 nm and em610 nm. Again, the relative fluorescence was corrected 
for variations in cell protein between individual wells.  
 
Measurement of Aconitase Activity 
Aconitase is inactivated by oxidative destabilization of a 4Fe:4S cuboid cluster in 
the active site. The loss of a single iron causes inactivation of the enzyme (and converts it 
into a DNA-binding protein called IRP-1 which controls various aspects of cellular iron 
metabolism). Therefore, changes in the activity of this particular enzyme serve as an 
intracellular 'detector' of endogenous ROS production. Cells (~5x106) were detached with 
trypsin/EDTA and washed with HBSS (1,000 xg x 10 min). The cells were suspended in 
1 ml of 50 mM Tris-HCl, pH 7.4, containing 0.6 mM MnCl2 and disrupted by ten 1 s 
bursts from a microtip sonic oscillator (Fisher Scientific, Pittsburgh, PA). The lysate was 
transferred to a chilled 1.5-ml Eppendorf tube. MnCl2 was included in the lysis buffer to 
limit the inactivation of aconitase by O2- during extract preparation (Gardner and 
Fridovich, 1991). Cell extracts were clarified by centrifugation for 10 min at 2,000 xg 
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and the supernatants were promptly assayed for aconitase activity, following the linear 
absorbance change at 340 nm at 25°C in a 1.0-ml reaction mixture containing 50 mM 
Tris-HCl (pH 7.4), 5 mM sodium citrate, 0.6 mM MnCl2, 0.2 mM NADP, 2 units of 
isocitrate dehydrogenase, and 50 µg of extract protein. One milliunit of aconitase activity 
was defined as the amount catalyzing the formation of 1 nmol of isocitrate per min. An 
initial lag in NADPH formation was seen in samples with low aconitase activity, which 
presumably reflects the delayed accumulation of cis-aconitase (Gardner et al., 1994; 
Kerbs and Holzach, 1952). In these cases, the linear rates during the latter half of a 60-
min assay were used for the determinations of aconitase activity. Results were corrected 
for measured protein concentrations. 
 
Estimation of Mitochondrial Protein Carbonyls 
Mitochondria were prepared by differential centrifugation using a modification of 
a previously described procedure (Arriaga et al., 2002; Fuller et al., 2002). Briefly, cells 
were washed twice with cold mitochondrial isolation buffer (250 mM sucrose, 10 mM 
Tris-HCl, pH 7.8, 1 mM EDTA, pH 8.0). The cells were diluted in this isolation buffer to 
8x106 cells/ml and disrupted by nitrogen cavitation at 4°C using an ice-cooled cell 
disruption bomb (Parr Instrument Co., Moline, IL). Following removal of large debris by 
centzifugation at 500 xg for 10 min at 4°C, the supernatants were centrifuged at 14,000 
xg for 20 min at 4°C to obtain crude mitochondrial pellets. The total carbonyl content of 
mitochondrial proteins was determined by reaction with 2,4-dinitrophenylhydrazine 
(DNP) using a slight modification of the method of Levine et al. (1990). Briefly, the 
mitochondria pellets containing ~300 µg of protein were incubated with 500 µl of 10 mM 
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DNP in 2 M HCl at room temperature for 1 hr with intermittent mixing. Following 
addition of 500 µl of 20% (w/v) ice-cold trichloroacetic acid (TCA), the samples were 
centrifuged at 11,000 xg for 3 min. The supernatant was discarded and the pellets were 
washed 3 times with 1 ml ethanol:ethyl acetate (1:1) to remove unreacted DNP. The 
protein pellet was redissolved in 0.6 ml of 6 M guanidine with 20 mM K2HPO4 (pH 
adjusted to 2.3 with 20% TCA) at 37°C and any insoluble material was removed by 
centrifugation at 11,000 xg for 3 min. The carbonyl content in the supernatant was 
measured spectrophotometrically at 375 nm. Results were calculated using a molar 
absorbance coefficient of 22,000 M-1 cm-1 and normalized for protein concentration. 
 
Determination of the Source of Intracellular ROS Generation 
We used particular inhibitors of the mitochondrial electron transport chain to 
determine whether the majority of intracellular ROS production was associated with 
mitochondrial metabolism and, if possible, to attempt to identify the major site(s) of ROS 
generation. This was done through the use of inhibitors of specific complexes such as the 
complex I inhibitor rotenone (ROT), complex II inhibitor thenoyltrifluoroacetone 
(TTFA), complex III inhibitor antimycin A (AA), and the uncoupler CCCP, all of which 
have been used previously to investigate mitochondrial ROS generation (see Figure 3). 
We should note at the outset that some of these inhibitors can actually enhance ROS 
generation by increasing the levels of electron-rich intermediates in the chain. It is 
generally accepted that complexes I and III (both of which generate ubisemiquinone) are 
the sites of most abundant electron leak (i.e., O2- formation). However, the relationship 
between electron leak from these mitochondrial electron transport complexes and 
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hyperoxic cell injury remains unclear. A summary of the sites of inhibitor action is shown 






























Determinations of O2 Consumption, Glucose Utilization and Lactate Production under 
Both Normoxic and Hyperoxic Conditions 
These parameters were measured in wild-type HeLa-20 and oxygen-tolerant 
HeLa-80 cell lines to provide some idea of the overall energy metabolism and oxygen 
consumption in hopes that the results might provide further information regarding which 




HeLa cell cultures were washed with PBS, detached with trypsin/EDTA and 
washed (1,000 xg x 10 min) in complete culture medium. Oxygen consumption was 
measured using a Gilson Oxygraph with a Clark electrode (Yellow Springs Instrument 
Co., Yellow Springs, OH). Respiration rates were measured using 3-5x106 cells 
suspended in a total volume of 3.0 ml of DMEM containing 10% FBS and supplemented 
with 17 mM glutamate at 37°C. A starting O2 concentration of 240 µM was assumed 
based on O2 solubility at sea level at 37°C (Chappell, 1964). 
 
Lactate production: 
Under standard culture conditions, the cells were incubated for varying periods of 
time up to 24 hr and lactic acid accumulation in the medium was determined. These 
assays were carried out using lactate dehydrogenase conversion of lactate to pyruvate 
(and the coupled oxidation of NADH to NAD) in the presence of hydrazine as a trap for 
the product (Gloster and Harris, 1962). Following completion of the reaction, the change 
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in absorbance at 340 nm was read spectrophotometrically (assumed molar absorption = 
6,290 M-1 cm-1). Results were expressed as nmol lactate formed per milligram of cell 
protein per unit time. 
 
Glucose consumption: 
The consumption of glucose by the same cultures in which we measured lactate 
production was measured in samples removed at the same times as above during the 
incubations. Glucose was measured using hexokinase-mediated formation of glucose-6-
phosphate followed by glucose-6-phosphate dehydrogenase-dependent formation of 
NADPH. Following completion of the reaction, the change in absorbance at 340 nm was 
read spectrophotometrically (assumed molar absorption = 6,220 M-1 cm-1). Results were 
expressed as nmol glucose consumed per milligram cell protein per unit time. 
 
Assays of the Activities of Respiratory Chain Components 
In order to measure the possible differences in the activities of the four major 
electron transport complexes in oxygen-tolerant and wild-type HeLa cells, assays of the 
activities of respiratory chain components were carried out as follows.  
   
Cell culture: 
For these experiments, the cells were cultured in polystyrene T-75 culture flasks 
(surface area 75 cm2) under 20% O2, 5% CO2.  Otherwise, the conditions of culture were 
as described above. 
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Preparation of cell lysates: 
Lysates of fresh cells (directly counted and adjusted to 6x106 cells/ml) were 
prepared by suspension in 0.25 M sucrose, 40 mM potassium chloride, 2 mM ethylene 
glycol-bis-aminoethyl ether N,N,N',N'-tetraacetic acid (EGTA), 1 mg/ml bovine serum 
albumin (BSA) and 20 mM Tris HCl (pH 7.2), and disruption by ten 1 s bursts from a 
microtip sonic oscillator (Fisher Scientific, Pittsburgh, PA). The lysate was centrifuged at 
2,000 xg for 10 min. The pellet was discarded and the supernatant used for enzyme 
activity assays described below (Jarreta et al., 2000).  
 
Measurement of the specific activity of the individual complexes of the 
respiratory chain was performed spectrophotometrically. A total of about 50 µg of protein 
was required for determinations of the activity of each complex component. Assays were 
performed at 37°C in 1 ml reaction volumes and the results were corrected for protein 
concentration measured as above. 
 
Rotenone-sensitive NADH-decylubiquinone oxidoreductase (complex I): 
This assay was carried out using the acceptor 2,3-dimethoxy-5-methyl-6-n-decyl-
1,4-benzoquinone (80 µM) and 200 µM NADH as donor in 10 mM Tris (pH 8.0) buffer 
containing 1 mg/ml BSA, 0.24 mM KCN and 0.4 µM antimycin A for 5 min. The 
addition of 4 µM rotenone allowed us to quantify the rotenone-sensitive activity. Activity 
was followed spectrophotometrically at 340 nm, typically over 5 min. To permeabilize 
the mitochondrial inner membrane to NADH, the sample was first incubated in distilled 
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H2O for 3 min at 37°C. Activity was calculated from the rate of decrease of NADH 
absorbance (ε = 6.3 mM-1cm-1) and expressed per µg protein (Jarreta et al., 2000). 
  
Succinate decylubiquinone 2,6-dichlorophenolindophenol (DCPIP) reductase (complex 
II): 
The assay was performed using 80 µM DCPIP as electron acceptor and 10 mM 
succinate as donor in a medium containing 50 mM KH2PO4 (pH 7.8), 2 mM EDTA, 1 
mg/ml BSA in the presence of 80 µM 2,3-dimethoxy-5-methyl-6-n-decyl-1,4-
benzoquinone, 0.24 mM KCN, 4 µM rotenone, 0.2 mM ATP and 0.4 µM antimycin A. 
Following a 2 min preincubation, 10 mM malonate was added to inhibit the oxidation of 
succinate (Jarreta et al., 2000). The activity was calculated from the rate of decrease in 
DCPIP @ 600 nm (ε = 19.1mM-1cm-1) (Kruidering et al., 1997). 
  
Ubiquinol cytochrome c reductase (complex III):  
This assay was carried out using 40 µM ferricytochrome c as the acceptor and 80 
µM decylubiquinol as the donor in a medium containing 10 mM KH2PO4 (pH 7.8), 1 
mg/ml BSA, 2 mM EDTA, in the presence of 0.24 mM KCN, 4 µM rotenone and 0.2 
mM ATP. Following 2 min pre-incubation, 1 µM antimycin A was added, allowing us to 
distinguish between the reduction of cytochrome c catalyzed by complex III vs. the 
nonenzymatic reduction of cytochrome c by the reduced quinone. The activity was 
calculated from the rate of cytochrome c reduction measured at 550 nm (ε = 19.1 mM-
1cm-1) (Kruidering et al., 1997). 
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Cytochrome c oxidase (COX):   
The assay involved the addition of 60 µM ferrocytochrome c in an isosmotic 
medium (10 mM KH2PO4, pH 6.5, 1 mg/ml BSA, 0.3 M sucrose) containing 2.5 mM n-
duodecylmaltoside to permeabilize mitochondrial membranes (Jarreta et al., 2000). The 
reaction was started by addition of the reduced cytochrome c and cell lysates. The 
activity was calculated from the rate of decrease in absorbance of ferrocytochrome c at 
550 nm (ε = 19.1 mM-1cm-1) (Kruidering et al., 1997) and results were normalized for 
protein. In addition, because accurate estimations of the activities of this mitochondrial 
electron transport terminal complex are affected by mitochondrial yield and integrity, the 
results were normalized using an invariant marker of mitochondrial enzyme activity, 
citrate synthase, as described below. 
 
Citrate synthase:  
This assay was performed as described by Williams et al. (1998) with minor 
modifications. It was based on the reaction of citrate synthase with oxaloacetate and 
acetyl-CoA to produce CoASH. Dithionitrobenzoic acid (DTNB) reacts with sulfhydryls 
in CoASH producing free thionitrobenzoate. 800 µl of 50 mM potassium phosphate 
buffer (K2HPO4 and KH2PO4, pH 7.4) was warmed to 37°C and then 10 µl of cell extract 
or crude mitochondrial extract was added along with DTNB and acetyl-CoA in final 
concentrations of 100 µM each. The reaction was started by addition of 100 µM 
oxaloacetate. The change in absorbance at 405 nm was monitored for 30 min (reflecting 
the formation of thionitrobenzoate) and results were expressed as nmol/min/mg protein. 
  43
The citrate syntase activity was calculated from the change in absorbance using ε = 13.6 
mM-1cm-1 for thionitrobenzoate (Bejma and Ji, 1999). 
 
Protein assay:   
Protein was determined using the Pierce BCA protein assay. Bicinchoninic acid 
(BCA), in the form of its water-soluble sodium salt, is a sensitive and highly specific 
chelator for cuprous copper (Cu+1) which is formed upon incubation of protein-
containing samples with added Cu+2.  The BCA/Cu1+ chelate (2:1) is detected at 562 nm. 
The procedure follows a standard microplate protocol in which samples were incubated 
for a total of 1 hr at 37°C.  
 
Preparation of Purified Mitochondria from Fresh Rat Liver 
Mitochondria were purified from rat liver using a combination of differential and 
Percoll gradient centrifugation (Croteau et al., 1997; Gasnier et al., 1993; Zhao et al., 
2003). All procedures were carried out at 4°C. Briefly, fresh liver was minced and 
homogenized in M-SHE buffer (0.21 M mannitol, 0.07 M sucrose, 10 mm Hepes pH 7.4, 
1 mm EDTA, 1 mm EGTA, 0.15 mm spermine, 0.75 mm spermidine). The following  
protease inhibitors were added:1 mM dithiothreitol (DTT), 2 µg/ml leupeptin, 2 µM 
benzamidine-HCl, 1 mM phenylmethylsulfonyl fluoride (PMSF). Unbroken cells and 
nuclei were pelleted at 500 xg for 10 min. The supernatant was centrifuged at 10,000 xg 
to pellet mitochondria and contaminating lysosomes which were resuspended and washed 
twice with M-SHE buffer. A 2-ml suspension was then layered onto 12 ml of Percoll 
solution (50% Percoll, 50% 2 M-SHE) and centrifuged for 1 hr at 50,000 xg in an SS-34 
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rotor. The brown mitochondrial band was collected, either by fractionating the gradient or 
by direct syringe aspiration. The purified mitochondria were pooled, diluted 10-fold with 
M-SHE buffer, again pelleted by centrifugation and, finally, resuspended in M-SHE 
buffer to a protein concentration of 1.0 µg/µl. The sample was frozen at –80˚C until use. 
We were aware that lysosomal contamination could be a particular problem with such 
preparations. Therefore, the activity of the lysosomal marker enzyme, beta-galactosidase, 
was measured to monitor the extent of possible lysosomal contamination.  
 
Preparation of Mitochondria from Cultured Cells 
All buffers were made with Milli-Q deionized water and filtered (0.2 µM) prior to 
use. Cell disruption was effected with a nitrogen bomb (Parr Instrument Co., Moline, IL) 
which was ice-cooled prior to use. The method for isolation of mitochondria was as 
previously described (Cossarizza et al., 1996; Masini et al., 1983) with some 
modifications. Between 106 and 107 cells were trypsinized and washed twice with cold 
PBS. The cell pellet was resuspended in 1 ml of sterile-filtered 0.25 M sucrose, 10 mM 
Tris (pH 7.8), and 1 mM EDTA (1 x STE buffer) at 4˚C. All the following steps were on 
ice. Cells were diluted in 1 x STE buffer to 8-10 x 106/1ml on ice. The 1 ml of cell 
suspension was transferred to the bomb charged with N2 to 700 psi for 23 min on ice 
followed by fast release of the N2 from the lower outlet to a 15-ml tube. As estimated by 
light microscopy, ~90% of the cells were disrupted by this procedure. The suspension 
was transferred to a 1.5 ml siliconized tube and unbroken cells and nuclei were pelleted at 
500 ×g for 10-15 min. The supernatant (containing mitochondria) was put in 1.5 ml 
siliconized microcentrifuge tubes. When the pellet obtained was big and <90% cells were 
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broken, we kept the pellet on ice and repeated the N2 cell disruption bomb one more time, 
combining the supernatants for centrifugation. Ten µl of supernatant was kept for protein 
assay. Finally, the supernatant was centrifuged at high speed at 14,000 xg for 20 min to 
pellet crude mitochondria. The crude mitochondria were resuspended in 1 x STE and 
washed once by centrifugation at 14,000 xg for 20 min. Three ml of the pellet 
resuspension was mixed with a 12% Percoll solution and layered onto a previously 
poured, 4 ml 26% Percoll, 4 ml 40% Percoll density gradient. The gradient was 
centrifuged at 35,000 xg for 10 min at 4°C. The resulting top layer containing myelin and 
other cellular debris was carefully removed using a Pasteur pipette and discarded. 
Fraction 2 (a light creamy color) (the interface between 12% and 26% Percoll) containing 
the mitochondria was removed by pipetting with a 200 µl gel loading tip and diluted 1:5 
in cold STE and centrifuged at 15,000 xg for 10 min. The resulting pellet was then 
resuspended in 1 ml of STE and centrifuged at 15,000 xg for 5 min. The final pellet of 
'pure' mitochondria was resuspended in 100 µl of STE containing 10 mg/ml bovine serum 
albumin (BSA) (Rajapakse et al., 2001) to stabilize the mitochondria. The purified 
mitochondria were immediately used to measure mitochondrial marker enzyme activities 
(as described above) or chilled in liquid nitrogen/-80°C for storage. 
 
Enzymatic Detection of the Lysosomal Marker Enzyme, β-Galactosidase (β-GAL) 
4-methylumbelliferyl-β-D-galactopyranoside, as a substrate, was prepared at a 
concentration of 30 mM in DMSO. 400 µl of this stock solution was added to 11.2 ml of 
0.2 M Na-citrate buffer (pH 4.5). Then 125 µl of this substrate solution was mixed with 
0.1 µg of mitochondria from rat liver or HeLa cells. The mixture was incubated at 37˚C 
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for 40 min. Thereafter, 100 µl of 6 M glycine-NaOH (pH 10.4) was added to the sample 
in order to stop the reaction. The assay was carried out in a 96-well cell culture plate and 
the fluorescence was read at 356/444 nm. 
 
JC-1 Staining as an Indicator of Mitochondrial Membrane Potential - Microscopy 
Cells were seeded in 48-well culture plates. The assay was performed when cells 
were 40-60% confluent. After rinsing once in HBSS, 4 µM of JC-1 in HBSS was added 
to cells. Cells were incubated at 37°C for 30 min. Following two further rinses in HBSS, 
cells were examined by fluorescence microscopy.  
 
JC-1 Accumulation as an Indicator of Mitochondrial Membrane Potential - Spectroscopy 
Cells were seeded in 48-well culture plates. The assay was performed when cells 
were 80-90% confluent. Ten µM CCCP was added to some wells and incubated for 1 hr. 
After rinsing once in HBSS, 10 µM of JC-1 in HBSS was added to cells. Cells were 
incubated at 37˚C for 30 min without CO2. After two further rinses in HBSS, 
fluorescence was read at ex535 nm, em590 nm using a spectrofluorescence plate reader. 
Following this, the HBSS was decanted and protein concentration within each well was 
measured. The results were expressed as FU per mg protein. 
 
Measurement of Heme Oxygenase Enzyme Activity 
Because of earlier reports indicating that over-expression of heme oxygenase 
would confer oxygen tolerance (Lee et al., 1996; Otterbein et al., 1999a), we measured 
the activity of this enzyme in HeLa-20 and HeLa-80 cells. Cells were collected from T-
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75 flasks by trypsinization when they had reached ~90% confluence. Following two 
washes in HBSS (with centrifugation at 1000 xg for 10 min at 4˚C), cell pellets were 
suspended in 1 ml lysis buffer: MgCl2 (2 mM) in phosphate buffer (NaxPOx, 100 mM, pH 
7.4), and frozen and thawed thrice (–70˚C). The cell suspension was sonicated by 15 x 1 
sec bursts in the lysis buffer on ice. The lysate pellet was obtained by centrifugation at 
18,800 xg for 10 min at 4˚C. The supernatant was collected and was added to a reaction 
mixture containing: 20 µM hemin, 2 mM glucose-6-phosphate, 0.2 units glucose-6-
phosphate dehydrogenase, 0.8 mM β-NADPH and 2 mg rat liver cytosol (rat liver 
biliverdin reductase is necessary to convert biliverdin to bilirubin) (Llesuy and Tomaro, 
1994). Total reaction volume was 400 µl. The mixture was incubated at 37˚C in the dark 
for 1 hr. The formed bilirubin was extracted with 600 µl chloroform (the reaction was 
performed in glass or eppendorf tubes because chloroform reacts with plastic) and the 
OD was measured at 464 and 530 nm. Heme oxygenase activity was expressed as pmol 
of bilirubin formed/mg of cell protein/60 min. (extinction coefficient, 40 mM-1cm-1 for 
bilirubin) (Motterlini, 1996).  
 
Electrophoretic Procedures and Western Blotting 
Materials:  
The following special materials were used in these electrophoretic procedures. 
Mouse anti-human cytochrome c oxidase subunits I, II, IV and Vb monoclonal antibodies 
and horseradish peroxidase-conjugated goat anti-mouse antibodies were purchased from 
Molecular Probes. Goat serum was from GIBCO LifeTechnologies (Grand Island, NY)., 
H2O2, antimycin A, rotenone, KCN, and the protease inhibitor mixture were from Sigma 
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Chemical Co. (St. Louis, MO).  10-20% gradient Tris-Glycine PAGE gels were from 
Invitrogen. SDS, polyoxyethylene-20-sorbitan monolaurate (Tween 20; enzyme grade) 
and protein standard solutions were obtained from Bio-Rad. X-Cell SureLockTM Mini-
Cell electrophoresis apparatus was from Invitrogen (Life Techonologies, Carlsbad, CA). 
ECL™-Plus was purchased from Amersham Pharmacia Biotech (Little Chalfont, Bucks, 
U.K). Reagent alcohol, polyoxyethylene-20-sorbitan monolaurate (Tween 20), potassium 
chloride, ethyl acetate and methanol were from Fisher Scientific Co. (Fair Lawn, NJ). 
Polyclonal rabbit anti-dinitrophenyl (DNP) and horseradish peroxidase-conjugated goat 
anti-rabbit antibodies were purchased from Zymed (San Francisco, CA). Immobilon™-P 
was purchased from Millipore (Bedford, MA). ECL™-Plus was purchased from 
Amersham Pharmacia Biotech (Little Chalfont, Bucks, U.K.).  
 
1. Preparation of RIPA cell lysates for western blots: 
RIPA buffer (Upstate Inc. Lake Placid, NY) contains 50 mM Tris-HCl, pH 7.4, 
150 mM NaCl, 1 mM PMSF, 1 mM EDTA, 5 µg/ml aprotinin, 5 µg/ml leupeptin, 1% 
Triton x-100,  1% sodium deoxycholate, 0.1% SDS. 2 x SDS sample buffer was from 
Biorad and contains 100 mM Tris, 25% glycerol, 2% SDS , 0.01% bromphenol blue, pH 
6.8, with 2-mercaptoethanol (2-ME) (10%) freshly added. 
  
(a) Harvest of cells from cell culture plates: 
Cells were detached using a rubber policeman and concentrated by centrifugation 
for 10 min at 800 xg. Cell pellets were washed twice with ice-cold PBS. One hundred µl 
of RIPA buffer was added to 106 cells, incubated on ice for 20 min and vortexed 2 to 3 
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times. Cells were disrupted by passage through a 28-gauge needle 8 times. The lysate was 
centrifuged for 3 min at 4°C at 9,000 rpm in a microfuge tube, then the supernatant was 
transferred to a clean tube. Protein concentration in each preparation was measured and 
adjusted to 5 µg/µl with RIPA lysis buffer. An equal volume of 2 x SDS sample buffer 
was added and the sample denatured by heating to 95°C for 5 min. Samples could be 
stored at -20°C for daily use or -80°C for long term storage. Repeated freeze thaw cycles 
were avoided.  
 
(b) Harvest of cells from cell culture flasks:  
Cells were released by trypsin and washed twice in cold PBS. The pelleted cells 
were lysed in 300 µl  lysis buffer [20 mM Tris–HCl, pH 7.5, 150 mM NaCl, 5 mM 
EDTA, pH 8.0, 1% Triton X-100, 10% glycerol, 1 mM PMSF, 5 mM DTT, and 20 µl/ml 
of a proteinase inhibitor cocktail (Novagen). The cell lysate was sonicated on ice to 
fragment the genomic DNA and centrifuged at 8,000 rpm for 4 min to remove debris. 
 
2. SDS-PAGE gels: 
(a) SDS-PAGE for HeLa cell lysates: 
Cell protein samples (50-100 µg) were electrophoresed under reducing conditions 
using an X-Cell Surelock Mini electrophoresis cell with a 10-20% (w/v) gradient 
polyacrylamide resolving gel, as described by Laemmli (Laemmli, 1970). Bio-Rad 
kaleidoscope prestained markers were used to track the progress of the proteins through 
the gel.  
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(b) SDS-PAGE for rat mitochondrial fraction: 
Ten µg of rat mitochondrial fractions were separated electrophoretically under 
reducing conditions using an X-Cell surelock Mini elctrophoresis cell with 10% 
polyacrylamide resolving gel as described by Laemmli (Laemmli, 1970). As above, Bio-
Rad kaleidoscope prestained markers were used to track the progress of the proteins 
through the gel. After staining with Coomassie blue (below), the gel was dried using 
NOVEX DryEaseTM Mini Gel Drying System (Invitrogen). 
 
3. Gel staining:  
Gels were stained with Coomassie blue and destaining was done with 40% (v/v) 
methanol, 10% (v/v) glacial acetic acid to remove background, usually 1-3 hr. Two 
identical gels were run at the same time, one of which was Coomassie stained and the 
other gel was processed immediately for immunoblotting. 
 
4. Immunoblotting: 
Protein samples, size-fractionated on 10-20% SDS-PAGE gels, were transferred 
to a PVDF membrane by electroblotting using 100 V x 1 hr @ 4°C. These membranes 
were blocked with 5% non-fat milk powder in 1 x PBS-T which contained 0.3% Tween-
20 and 1% non-immune goat serum to reduce background. Following an overnight 
incubation with constant gentle agitation, the membranes were incubated at room 
temperature for 1.5 hr with mouse monoclonal antibodies against COX I (1:500 dilution, 
2 µg/ml in 1 x PBST, 0.3% Tween-20), II (1:500 dilution, 2 µg/ml in 1 x PBST, 0.3% 
Tween-20), IV (1:500 dilution, 2 µg/ml in 1 x PBST, 0.3% Tween-20), or Vb (1:1000 
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dilution, 1 µg/ml in 1 x PBST, 0.3% Tween-20). After washing 3 X for 10 min each time 
with 1 x PBST (0.5% Tween-20), blots were then incubated with a horseradish 
peroxidase-conjugated goat anti-mouse secondary antibody (1:1500 dilution, 0.67 µg/ml 
in 1 x PBST, 0.3% Tween-20). After washing 5 X for 10 min with 1 x PBST, 
immunostaining was developed using an enhanced chemiluminescence, ECL™-Plus 
Western blotting detection kit, according to the manufacturer's instructions (Amersham 
Pharmacia Biotech).  
 
5. Membrane staining:  
In order to control the amount of protein transferred to the PVDF membranes, 
Ponceau S staining was carried out. After transfer, the membrance was re-wetted in 100% 
methanol and then rinsed in water. The membrane was incubated into 1x Ponceau S (10X 
Ponceau S concentrated solution from Sigma diluted with H2O) for 15 min at room 
temperature. The Ponceau S was eluted with 5% non-fat milk in PBST or TBST and the 
membrane was ready for blocking.  
 
6. Immunoblotting detection of β-actin as control:  
The PVDF blots were re-wetted using 100% methanol, rinsed with water and then 
2 X with PBST for 5 min. The membrane was incubated with 1 x Re-blot strip Buffer 
(Chemicon Inc., Temecula, CA) for 15 min at room temperature with gentle agitation. 
Following this, the membrane was blocked with 5% non-fat milk in 1 x PBST (0.3%) 
with 1% goat serum to reduce background. After rinsing with 1 x PBST, the membrane 
was incubated with primary anti-β−actin (1:5000 dilution in 5% non-fat milk in 0.3% 
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PBST + 1% goat serum) for 1 hr at room temperature, washed thrice with 1 x PBST 
(0.5%), each time for 5 min, and then incubated with secondary antibody:HRP 
conjugated-goat anti-mouse (1:8000 dilution in 5% non-fat milk in 0.3% PBST + 1% 
non-immune goat serum) for 45 min at room temperature. Following this, the membrane 
was washed 5 times with 1 x PBST (0.5%) and developed using enhanced 
chemiluminescence ECL™-Plus Western blotting detection kit as above. 
 
Real-Time Reverse Transcript Polymerase Chain Reaction (RT-PCR) 
Materials:  
RNeasy Mini kit and Omniscript™ Reverse transcriptase and SYBR® Green were 
purchased from QIAGEN (QIAGEN Inc., Valencia, CA). RNase-free water was obtained 
from GIBCO. Premix Taq™ (Ex Taq™ R-PCR Version) was purchased from Fisher 
(Fisher Scientific Inc., Hampton, NH).  
 
Ribonucleases (RNases) are very stable and active enzymes that generally do not 
require cofactors to function. Since RNases are difficult to inactivate and even minute 
amounts are sufficient to degrade RNA, great care was taken to avoid inadvertently 
introducing RNases into the RNA sample during or after the isolation procedure. All the 
following procedures were handled in an RNase-free environment.  
 
Isolation of total RNA from HeLa cells:  
HeLa cells were cultured in 6-well plates. 5x105 cells were lifted using a sterilized 
policeman. The cells were transferred to an RNase-free sterilized polypropylene 
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eppendorf centrifuge tube and pelleted by centrifugation at 9,000 rpm for 1.5 min at room 
temperature. The culture medium was completely aspirated since incomplete removal of 
the cell culture medium would inhibit lysis and dilute the lysate, thereby affecting the 
conditions for binding of RNA to the RNeasy silica-gel membrane. Both effects might 
reduce RNA yield. Cell pellets could be stored at –70˚C for later use or used directly for 
RNA extraction. The number of cells was determined before freezing or direct analysis. 
The pelleted cells were disrupted by addition of 350 µl (for <5x106 cells) of lysis buffer 
and homogenized by passing the cell lysate 5 times through a 28-gauge needle fitted to an 
RNase-free syringe. 350 µl of ethanol was then added to the cell lysate, creating 
conditions that promote selective binding of RNA to the RNeasy silica-gel membrane. 
The sample was then applied to the RNeasy mini column. Total RNA binds to the 
membrane, contaminants are efficiently washed away, and high-quality RNA was eluted 
in 30 µl of RNase-free water.  
 
Quantification of RNA:  
The concentration of RNA was determined by measuring the absorbance at 260 
nm (A260) in a spectrophotometer. An absorbance of 1.0 at 260 nm corresponds to 40 µg 
of RNA per ml (A260 of 1.0 = 40 µg/ml RNA). Since this relation is valid only for 
measurements in water, the RNA sample was diluted in RNase-free water when 
measuring RNA samples. The ratio of the readings at 260 nm and 280 nm (A260/A280) 
provides an estimate of the purity of RNA with respect to contaminants that absorb in the 




For reverse transcription, first-strand cDNA was synthesized using 1 µg of RNA 
with Omniscript Reverse Transcriptase from QIAGEN (QIAGEN Inc., Valencia, CA). 
One µg of total RNA solution was mixed with 10 µM  random hexadeoxyribonucleotides 
{pd(N)6} primers (Promega, Madison, WI), ice-cooled and subjected to first-strand DNA 
synthesis using 4 units of Omniscript Reverse Transcriptase and 10 units of RNase 
inhibitor (Promega, Madison, WI) in 20 µl reaction for 1 hr at 37°C.  
 
SYBR Green real-time reverse transcriptase (RT)-PCR assay:  
The PCR primers for COX Vb and β-actin (as a control) were designed by Jason 
Chesney and Sucheta Telang (University of Louisville) using a the Primer designer 2.0  
software program from Invitrogen (Invitrogen Life Technologies, Carlsbad, CA)  
according to the published cDNA sequences (summarized in Table 2) (Grandjean et al., 
2002). Premix Taq™ (Ex Taq™ R-PCR Version) was used for the second strand cDNA 
synthesis and DNA amplification. Premix Taq™ (Ex Taq™ R-PCR Version) is a premix 
reagent designed specially for RT-PCR. The polymerase used in this premix reagent is 
TaKaRa Ex Taq for Hot Start PCR which is mixed with the neutralizing monoclonal 
antibody to Taq DNA polymerase. Real time monitoring of PCR was performed by 
addition of SYBR® Green as a detection reagent using the Smart Cycler® System. The 
reaction was performed with 1.5 µl template of RT product of total COX Vb RNA, 5 µl 
Premix Taq™ (Ex Taq™ R-PCR Version) (5 x), 2 µl diluted SYBR Green PCR and 0.3 
µM primers (forward and reverse) in a total volume of 25 µl. The amount of template 
was <30 ng since excess template may cause depletion of SYBR Green and interfere with 
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the correct monitoring. PCR was performed after an initial incubation at 95°C for 30 sec 
in order to activate the Hotstartaq DNA polymerase. Then, 22-40 cycles were run at 
denaturation -95°C for 10 s, annealing -58°C for 20 s, extension -72°C for 30 s on the 
Smart Cycler System. Each sample was run with β-actin as a reference gene. Results 
were obtained by measuring the cycle threshold (CT), the first cycle in which there is 
significant increase in fluorescence above the background, and which correlates to the 
log-linear phase of PCR amplification. Generally, the runs were stopped at 8 cycles after 
the cycle threshold (CT) appeared. The relative quantification in mRNA levels was 
evaluated by the ratio between the target gene, COX Vb, and the housekeeping gene, β-
actin. Data calculation was based on the ‘Delta-Delta method’ using the equation: R 
(ratio) = 2 -[∆CT sample- ∆CT control]  (Livak and Schmittgen, 2001). 
 
Small Interference RNA (siRNA) Transfection 
RNA interference (RNAi) works through a conserved biological response to 
double-stranded RNA and involves the use of active small interfering RNA (siRNA). 
Conjugation of this with target mRNA activates an RNase III endonuclease complex, 
Dicer. The 21–23 nt siRNAs will, thereby, silence homologous gene expression by 
mediating, in a sequence-specific manner, degradation of the transcribed mRNA 
(Hannon, 2002). 
 
siRNA primer design: 
Two siRNA duplexes targeting the COX Vb gene were designed and obtained 
from Dharmacon (Dharmacon, Inc., Lafayette, CO). The first target sequence was 
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AAAGUAGGCUGCAUCUGUGAA. The corresponding siRNA duplex #1 (S1) was 21 
nt. Sense sequence: 5’-AGUAGGCUGCAUCUGUGAAdTdT-3’; antisense sequence: 5’-
UUCACAGAUGCAGCCUACUdTdT-3’'. The second target sequence was 
AACAGUAAAGACUAGCCAUUG. The corresponding siRNA duplex #2 (S2) was also 
21 nt. Sense sequence: 5’-CAGUAAAGACUAGCCAUUGdTdT-3’; antisense sequence: 
5’'-CAAUGGCUAGUCUUUACUGdTdT-3’. 
 
Cell cultures and siRNA transfection:  
HeLa-80 cells were cultured at 37°C in a humidified 5% CO2/air atmosphere in 
DMEM medium with 10% (v/v) FBS. One day before transfection, HeLa cells were 
seeded at sub-confluent density (8x104 cells per well in 6-well plates). When the 
procedure was started, the cultures were fed with enriched DMEM medium (10% FBS, 
supplemented with high glucose 4 g/L, 100 µg/ml pyruvate and 50 µg/ml uridine). 
Transfection with siRNA was done with Oligofectamine (Invitrogen, Carlsbad, CA), 
following the manufacturer's guidelines with some modifications. Two different 
concentrations of siRNAs (20 nM or 100 nM) were employed in the experiments. siRNA 
was diluted with OptiMEM medium (no serum and no antibiotics) to a final volume of 
200 µl and incubated at room temperature for 20 min. Oligofectamine also was diluted in 
OptiMEM to a final volume of 50 µl and incubated at room temperature for 5 min. Next, 
the diluted siRNA was combined with the diluted Oligofectamine (total volume 250 µl) 
and the mixture was incubated at room temperature for 30 min to allow the siRNA–
Oligofectamine complex to form. Two ml of enriched DMEM was added to wells in 
which transfection with siRNA was to be done. Then, 250 µl of the siRNA–
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Oligofectamine complex was added to the cells with thorough mixing. Cells were further 
incubated for 48 hr at 37°C. Then the cells were processed for the evaluation of COX Vb 
protein production by Western blotting analysis and evaluation of COX Vb mRNA levels 
by real time RT-PCR. Mock transfections were carried out with Oligofectamine alone 


















Part I. ROS Produced by Mitochondria are Causally Related to Hyperoxic Cell Damage 
We began by investigating the general and rather obvious concept that hyperoxic 
damage might derive from enhanced cellular production of ROS (Chance et al., 1979; 
Castro and Freeman, 2001; Gerschman et al., 1954), incidentally generated from normal 
cellular respiratory processes. Even under normoxia, a fraction of the reducing 
equivalents handled by mitochondrial metabolism (variably estimated at 0.1 - 2%) escape 
the respiratory chain as O2-, most of which will be converted to H2O2 (Chance, 1979; 
Cross, 1991; Hansford, 1997). As reviewed above, a likely source of much of this 
electron ‘leak’ from the respiratory chain is ubisemiquinone (the half reduction product 
of ubiquinone) (Turrens et al., 1985; Freeman and Crapo, 1981; Sanders et al., 1993). 
Despite the weight of evidence in favor of mitochondrial ROS being involved in 
hyperoxic cell damage, there have been recent reports to the contrary (Budinger et al., 
2002). We hypothesized that if mitochondrial metabolism were, in fact, responsible for 
enhanced ROS production under hyperoxic conditions, then cells with impaired 
mitochondrial respiration might be relatively resistant to increased O2 tensions.  
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As a test of this general hypothesis, we employed HeLa cells and used three 
different strategies to diminish mitochondrial metabolism. First, using ethidium bromide 
(EB) pressure, we ablated the mitochondrial DNA, producing cloned ‘ρo’ HeLa cells with 
a very low rate of respiration. We also re-introduced normal mitochondria into this ρo 
clone to control for possible unanticipated mutations in nuclear DNA caused by long-
term EB exposure. Second, we exposed the wild-type HeLa cells to carbonyl cyanide m-
chlorophenylhydrazone (CCCP). This protonophore uncouples mitochondrial respiration, 
increases O2 consumption but, paradoxically, diminishes mitochondrial ROS production. 
Third, we treated HeLa cells with the antibiotic chloramphenicol which disrupts the 
synthesis of mitochondrial inner membrane proteins, thereby preventing the assembly of 
a complete mitochondrial electron transport complex. 
 
Control and variously treated HeLa cells were then exposed to elevated 
atmospheric O2 (80% O2/5% CO2) and the growth and survival of the cells were 
followed. Overall, the results of these experiments lend strong support to the general 
concept that interactions between respiring mitochondria and O2 are the major mechanism 
responsible for hyperoxic cell damage.  
 
Α. ρo cells have a growth and survival advantage in hyperoxia 
To produce a line of cells having diminished respiration, we treated cultured 
HeLa cells with EB for 8 months. Following this, clones were derived from candidate 
cells found to be negative for JC-1 staining (which estimates mitochondrial membrane 
potential) and these were cultured for three weeks to ensure that ρo status was durable. 
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One negative clone was selected and found to have no PCR-amplifiable mtDNA (25 
cycles) (results not shown). These cells also had very low cytochrome oxidase activity 
and almost undetectable O2 consumption (Table 3). The growth and survival of these ρo 
cells was compared to that of the wild-type cells under 20% and 80% O2.  As shown in 
Figure 5, both wild-type and ρo cells exhibited normal replication when cultured under 
normoxic conditions. However, under 80% O2, the ρo cells had a distinct survival 
advantage, with a growth rate approximately 70% that observed under normoxic 
conditions. In contrast, the wild-type cells progressively died after ~5 days under 
hyperoxia (Figure 5).  
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Table 3. Cytochrome c oxidase activity and O2 consumption in wild-type and respiration-









Wild-type 7.36 ± 0.85 16.56 ± 1.60 
ρo  1.35 ± 0.34 *     0.14 ± 0.01 * 
cybrids 6.89 ± 0.77 10.06 ± 1.02 
Chloramphenicol-treated 0.20 ± 0.08 *      0 ± 0 * 
 
Results are expressed as means ± 1 SD (n = 4 separate cell preparations). 






















































Figure 5. Growth characteristics of wild-type (A) and ρo HeLa cells (B) in normoxic 
(20% O2) and hyperoxic (80% O2) conditions. Medium was replenished every 4 days and 
the atmosphere of the cells grown under 80% O2 was replaced every 48 hr. Cell growth 
was monitored by repeated microscopic examination of marked sectors of the culture 
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dishes. Note the log scale. Under 80% O2, following an early period of cell replication, 
wild-type HeLa cells stopped growing and progressively died after 5 days; however, ρo 
cells continued to grow at a rate approximately 70% that observed under 20% O2. The 
cell numbers at confluence are indicated by the shaded area at top. (−− = wild-type and 
−○− = ρo under 20% O2; −¡− = wild-type and −S− = ρo under 80% O2). In each case, 
results are means ± 1 SD of three independent cultures. 
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Β. ρo cybrids exhibit wild-type sensitivity to hyperoxia 
While the resistance of the ρo HeLa cells to hyperoxia was quite likely a result of 
diminished mitochondrial respiration and ROS production, EB is mutagenic for both 
mitochondrial and nuclear DNA. To control for possible effects due to simultaneous 
nuclear mutations, in a sub-set of ρo cells normal mitochondria were re-introduced via 
fusion with normal human platelets. As shown in Figure 6, the previously ρo HeLa cells 
once again containing functional mitochondria showed wild-type susceptibility to 
hyperoxia, having diminished early growth and later cell death under these conditions. 
Note that the re-introduction of normal mitochondria also restored O2 consumption to 
near normal rates (Table 3). As might be expected, ROS production in the cybrids was 
similar to that in wild-type HeLa cells and much higher than ρo cells under both 20% and 




























Figure 6. Growth characteristics of ρo HeLa cells (−S−) and cybrids (−z−) in hyperoxic 
(80% O2) conditions. Following an early period of cell replication, cybrids stopped 
growing and progressively died after about 5 days as did wild-type HeLa cells (Figure 












































Figure 7. Mitochondrial ROS generation in wild-type, ρo and cybrid HeLa cells. ROS 
production was evaluated under both 20% O2 (A) and 80% O2 (B) during a 4 hr 
incubation with the fluorescent probe dihydroethidium. ROS generation (expressed as 
fluorescence units [FU]) was reduced by 90% and 95% in ρo HeLa cells under 20% O2 
(A) and 80% O2 (B), respectively, and was restored to near-normal in the cybrid cells (* 
P < 0.01, n = 6). 
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C. ρo cells are not resistant to oxidant killing 
One alternative explanation to the findings presented above might be that 
something about ρo status – aside from effects on cellular respiration and associated ROS 
generation – might confer relative resistance to oxidant challenge. As a partial test for 
this possibility, we measured cell killing by increasing amounts of both H2O2 (Figure 
8A) and t-butyl hydroperoxide (Figure 8B). The results indicate that, if anything, the O2-
tolerant ρo cells are somewhat more susceptible to oxidant killing. Interestingly, and for 
presently unknown reasons, restoration of normal mitochondria into these cells appears to 
improve resistance to oxidant killing. Overall, these results indicate that the tolerance of 

























































Figure 8. Susceptibility of wild-type, ρo and cybrid HeLa cells to oxidant-mediated cell 
death. Wild-type HeLa cells, ρo and cybrids cells were seeded at 4x104 cells per well in 
48-well plates and grown for 3 days at which time the cells (~90% confluent) were 
exposed to H2O2 (A) or t-butyl hydroperoxide (B) in HBSS at 37°C for 2 hr. Upon return 
to complete culture medium, cell viability was estimated 10 hr later using reduction of 




D. Differences in intracellular ROS generation in wild-type vs. ρo cells 
If ρo cells avoid the cytotoxic and cytocidal effects of hyperoxia by virtue of 
diminished mitochondrial production of ROS, then this latter also should be reflected in 
other measures of intracellular ROS production. Two additional parameters generally 
support this idea. First, we measured aconitase activity under normoxic and hyperoxic 
conditions. Given the susceptibility of aconitase to inactivation by ROS (Gardner et al., 
1994), changes in the activity of this enzyme can be used as an indirect measure of 
intracellular ROS production. As shown in Figure 9, exposure of the wild-type HeLa 
cells to hyperoxia for 24 hr caused a ~70% decrease in total aconitase activity whereas 
the (already low) aconitase activity in ρo HeLa cells was relatively unaffected. Note that 
the activity of a reference enzyme, citrate synthase, was unchanged following similar 
exposure of either wild-type or ρo cells to hyperoxia (data not shown). Second, because 
oxidation is most prominent in mitochondria (Das et al., 2001), we also measured 
mitochondrial protein carbonyl content as an indication of the extent of protein oxidation. 
As shown in Figure 10, protein carbonyls increased significantly in wild-type HeLa cells 
after 48 hr culture in 80% O2. In contrast, ρo HeLa cells showed no significant change in 

































Figure 9. Wild-type, but not ρo, HeLa cells show hyperoxia-dependent inhibition of 
aconitase activity. Following 24 hr culture under 20% (black bars) or 80% (gray bars) O2, 
aconitase activity was measured. Note the marked (~70%) loss of aconitase activity in 


































Figure 10. Wild-type, but not ρo, HeLa cells show hyperoxia-dependent increased 
mitochondrial protein carbonyl formation. Following 48 hr exposure to either 20% (solid 
bars) or 80% (cross-hatched bars) O2, mitochondrial protein carbonyl content was 
measured. Whereas wild-type cells showed a significant increase in protein carbonyls, 
there was no change in ρo cells. Results represent means ± 1 SD of four independent 
cultures (* P < 0.01). 
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E. Pharmacologic suppression of mitochondrial ROS production also permits the survival 
and growth of wild-type HeLa cells under hyperoxia 
If ρo cells are, indeed, protected against the cytostatic and cytotoxic effects of 
hyperoxia by virtue of diminished mitochondrial ROS production, then other maneuvers 
which similarly suppress ROS generation also should favor cell survival in hyperoxia. 
Indeed, two additional lines of evidence support this conclusion. First, wild-type HeLa 
cells were exposed to hyperoxia in the presence of the protonophoric uncoupler, CCCP. 
Like other uncouplers, this protonophore increases cell respiration (Kessler et al., 1976). 
Paradoxically, as shown in Figure 11A, CCCP causes a ~60% decrease in ROS 
production under both normoxic and hyperoxic conditions. (This is likely because CCCP 
accelerates the passage of electrons down the transport chain and thereby depletes 
electron-rich intermediates such as ubisemiquinone.) This diminished intracellular ROS 
generation is associated with enhanced cell survival under hyperoxia, although some 
toxicity of the agent itself is reflected in the fact that these cultures did not reach 

















































Figure 11. The protonophoric uncoupler, CCCP, decreases ROS production and 
enhances the survival of HeLa cells under hyperoxia. (A) ROS production was evaluated 
in wild-type HeLa cells under 20% O2 and 80% O2 during 4 hr incubations with 
dihydroethidium in the presence and absence of CCCP. ROS production in treated cells 
  75
was reduced 60% and 56% under normoxia and hyperoxia, respectively (P < 0.01, n = 6). 
(B) Wild-type HeLa cells grown in the continuous presence of 1 µM CCCP were 
relatively resistant to the cytostatic and cytocidal effects of hyperoxia. Results represent 





As an additional means of achieving decreased mitochondrial ROS generation, 
other cultures of wild-type HeLa cells were grown in the presence of chloramphenicol. 
As would be expected–and in contrast to CCCP-treated cells (vide supra)-these 
chloramphenicol-treated HeLa cells exhibited greatly decreased O2 consumption (Table 
3) and decreased ROS production under both 20% and 80% O2 (Figure 12A). 
Subsequent exposure of these cells to hyperoxia (in the continued presence of 
chloramphenicol) revealed a substantial improvement of both growth and survival under 
















































Figure 12. (A) Inhibition of mitochondrial protein synthesis with chloramphenicol 
decreases ROS production and increases survival of HeLa cells under hyperoxia. Wild-
type HeLa cells were pretreated with 50 µg/ml chloramphenicol for 5 days to inhibit 
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mitochondrial protein synthesis. ROS production was evaluated under 20% O2 and 80% 
O2 during 4 hr incubations with dihydroethidium. ROS production in treated cells was 
reduced 59% and 45% under normoxia and hyperoxia, respectively (P < 0.01, n = 4). (B) 
Wild-type HeLa cells grown under 80% O2 in the continual presence of chloramphenicol 
were relatively resistant to the cytostatic and cytocidal effects of hyperoxia. Results 
represent means ± 1 SD of three independent cultures. 
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F. Summary of Part I.  
The above results provide substantial support for the idea that the adverse effects 
of hyperoxia largely derive from enhanced mitochondrial formation of ROS (Chance et 
al., 1979; Castro and Freeman, 2001; Gerschman et al., 1954). The amplified cellular 
ROS production under hyperoxia most likely arises from increased reduction of O2 to O2- 
in metabolically-dependent reactions. These ROS may then interact with transition 
metals, which are present even in normal cells, to generate even more damaging species 
such as hydroxyl and metal-centered radicals. The increased ROS generation during 
exposure to hyperoxia can potentially overwhelm antioxidant defense mechanisms, even 
in the presence of exogenously administered antioxidants (Ho et al., 1998a).   
 
To determine whether ROS of mitochondrial origin might be involved in cell 
injury and death under hyperoxia, we created ρo HeLa cells and exposed them to 
hyperoxia. Such ρo cells, lacking most mitochondrial DNA, still contain intact 
mitochondria but lack critical subunits of the electron transport chain and do not respire. 
In contrast to wild-type HeLa cells, we find that ρo cells are relatively resistant to the 
cytostatic and cytocidal effects of hyperoxia. This tolerance to high O2 concentrations 
coincides with diminished intracellular production of ROS during exposure to hyperoxia 
as estimated by (i) dihydroethidium oxidation, (ii) suppression of aconitase activity and 
(iii) accumulation of protein carbonyls. Both susceptibility to hyperoxic damage and 
intracellular ROS generation are restored in cybrids in which normal human 
mitochondria have been re-introduced into the ρo cells. 
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From these results, we conclude that the very organelles which permit such 
efficient metabolism under normoxic conditions are a clear and present danger under 
hyperoxia. The relentless mitochondrial production of ROS, easily detected under 
normoxic conditions, is increased under elevated partial pressures of O2. The likely net 
effect of this amplified ROS production - at least under in vitro culture conditions - is 
cessation of cell growth followed by cell death. Our results indicate that strategies which 
act to limit respiration and/or suppress intracellular ROS production will significantly 















Part II:  Investigations of a Unique Line of Oxygen-Tolerant HeLa Cells 
The results reported in Part I indicted ROS of mitochondrial origin in hyperoxia-
mediated cytostasis and cell death. In the following investigations we employed an 
unusual line of HeLa cells (‘HeLa-80’) selected for tolerance to step-wise increases in 
partial pressures of O2. Our hope was that elucidation of the mechanisms underlying this 
unusual oxygen tolerance might lead to a more comprehensive understanding of oxygen 
toxicity and, perhaps, suggests ways in which oxygen tolerance might be conferred to 
normal cells and tissues. 
 
In attempting to understand the oxygen tolerance of the HeLa-80 strain, we 
focused our attention on ROS production. As described below, we found that the HeLa-
80 cells produced less ROS under both normoxic and hyperoxic conditions. While 
searching for a possible reason for this, we also observed that addition of CCCP 
(described above) blocked ROS production in both wild-type HeLa-20 cells and HeLa-80 
cells. As also indicated above, this may be because the dissipation of the proton gradient 
across the inner mitochondrial membrane accelerates electron transport and, thereby, 
depletes electron-rich intermediates (perhaps most importantly ubisemiquinone at 
complex III). This suggested to us that something similar might have somehow occurred 
in the oxygen-tolerant HeLa-80 cells.  
  
A. HeLa-80 cells grow and survive in hyperoxia 
We began by affirming the previously reported oxygen tolerance of the HeLa-80 
cells (cell lines were very generously provided by our collaborator, Dr. Hans Joenje 
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(Institute of Human Genetics, Free University, Amsterdam, The Netherlands). Cell 
growth under 80% O2 was monitored by microscopic examination of particular sectors of 
the culture plates. As shown in Figure 13A (and previously reported by Dr. Joenje 
(Joenje et al., 1985a), when cultured under 80% oxygen and 5% CO2 at 37°C, the wild-
type (‘Hela-20’) cells ceased growing after 5-6 days and then underwent extensive cell 
death. In contrast, the Hela-80 cells continued to grow throughout the period of exposure 
(Figure 13B). As shown in Figure 13, both Hela-20 and HeLa-80 cells exhibited normal 



















































    
    
 
Figure 13.  Growth characteristics of wild-type HeLa-20 (A) and oxygen-tolerant HeLa-
80 cells (B) in normoxic (20% O2) and hyperoxic (80% O2) conditions. Medium was 
replenished every 4 days and the atmosphere of the cells grown under 80% O2 was 
replaced every 48 hr. Cell growth was monitored by repeated microscopic examination of 
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marked sectors of the culture plates. Note the log scale. Under 80% O2, following an 
early period of cell replication, wild-type HeLa-20 cells stopped growing and 
progressively died after 5 days; however, oxygen tolerant HeLa-80 cells continued grow 
at a rate approximately the same as that observed under 20% O2. The cell numbers at 
confluence are indicated by the shaded area at top. (“”= HeLa-20 and “○”= HeLa-80 
under 20% O2; “¡”= HeLa-20 and “S”= HeLa-80 under 80% O2). In each case, results 
are means ± 1 SD of three independent cultures.  
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Preliminary analyses did not reveal any obvious differences in mitochondrial 
number or membrane potential (Figure 14). Figure 15 (bottom) presents the results of 
staining of these cells with JC-1 (a fluorescent dye which, by its mitochondrial 
concentration, specifically reflects mitochondrial membrane potential. In cells loaded 
with this dye, the ratio between red fluorescence (JC-1 aggregates concentrated within 
mitochondria) and green fluorescence (cytoplasmic JC-1 monomers) reflects 
mitochondrial membrane potential. Thus, JC-1 simultaneously probes mitochondrial 


























Figure 14. Changes in mitochondrial membrane potential (reflected by JC-1 staining) in 
the absence and presence of 10 µM CCCP. Note the profound (and expected) decrease in 






Figure 15. HeLa-20 and HeLa-80 cells were grown under 80% oxygen for 10 days. 
These pictures were taken on day 10 by normal light microscopy (top two panels) and 
after JC-1 staining (which reveals mitochondria with normal membrane potential). 
Note: After 10 days of growth under 80% oxygen, HeLa-20 cells are sparse with 









B. HeLa-20 and HeLa-80 cells do not differ in susceptibility to oxidant killing 
One obvious explanation for the oxygen tolerance of the HeLa-80 cells might be a 
generalized resistance to the oxidants produced under hyperoxic conditions. However, we 
reaffirmed Dr. Joenje’s earlier findings (Gille et al., 1988; Joenje et al., 1985b) that there 
are no significant differences in antioxidant enzymes, such as superoxide dismutases, 
catalase, reduced glutathione, glutathione reductase and glutathione peroxidase, between 
these two strains of HeLa cells. In view of earlier reports that elevated heme oxygenase-1 
might protect against hyperoxia-induced lung damage (Lee et al., 1996; Otterbein et al., 
1999a), we also measured total heme oxygenase activity. Once again, no significant 
differences were found (Figure 16). We also measured the Bcl-2 levels in these two cell 
lines because some reports suggested that over-expression of Bcl-2 might be associated 
with oxygen tolerance (Budinger et al., 2002). Here as well,  no significant differences 
were observed (Figure 17). As a more direct test of the overall oxidant defenses of these 
two cell lines, we investigated cell killing by increasing amounts of both H2O2 and t-
butylhydroperoxide. As shown in Figure 18, these two cell lines show nearly identical 
killing curves and LD50s for both oxidants. For H2O2, LD50 is 140 ± 21 µM and 125 ± 28 
µM, n=4 (Figure 18A); for t-butylhydroperoxide, LD50 is 470 ± 35 µM and 410 ± 62 

































Figure 16. Total heme oxygenase activities measured in HeLa-20, HeLa-80 and 



















Figure 17. Bcl-2 levels were measured in HeLa-20, HeLa-80, ρ° HeLa-20 and the 
corresponding cybrids. The assay was carried out at absorbance 450 nm. The Bcl-
2 units were calculated by Bcl-2 ELISA standard curve. No significant difference 














































Figure 18. Susceptibility of wild-type HeLa-20 and oxygen-tolerant HeLa-80 cells to 
oxidant-mediated cell death. HeLa-20 and HeLa-80 cells were seeded in 48-well plates at 
an initial density of 2x104 cells per well and grown 3 days at which time the cells (~90% 
confluent) were exposed to H2O2 (A) or t-butyl hydroperoxide (B) in HBSS at 37°C 
without CO2 for 2 hr. Upon return to complete culture medium, cell viability was 
estimated 10 hr later using reduction of alamarBlue (ex530 nm, em590 nm) (“■”= HeLa-
20; “∆”= HeLa-80). 
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C. Oxygen tolerant HeLa-80 cells exhibit decreased ROS production under both 
normoxia and hyperoxia 
The above results directed our attention to possible differences in the production 
of ROS by HeLa-20 vs. HeLa-80 cells. This was first estimated using the fluorescent 
probe dihydrodichlorofluorescein diacetate (DCF-DA). This cell permeable non-
fluorescent probe enters cells by passive diffusion whereupon the two acetate groups are 
esterolytically cleaved. Within the cell, the probe can be oxidized in a reaction which 
requires H2O2 and a peroxidase or pseudoperoxidase such as cytochrome c or redox-
active Fe. Upon oxidation, the probe is converted to highly fluorescent 2',7'-
dichlorofluorescin. The results (Figure 19) indicate that the steady state production of 
ROS by Hela-80 cells is substantially less than that of HeLa-20 cells, supplying at least 
partial support for our general hypothesis that the tolerance of HeLa-80 cells might arise 




























Figure 19. Mitochondrial ROS generation in wild-type HeLa-20 and oxygen-tolerant 
HeLa-80 cells. ROS production was evaluated under 20% O2 detected by oxidation of the 
fluorescent probe, dihydrodichlorofluorescein diacetate (DCF-DA) in the presence and 
absence of the protonophoric uncoupler carbonyl cyanide m-chlorophenylhydrazone 
(CCCP). Even under normoxia, ROS production by HeLa-80 cells is markedly lower than 
that by HeLa-20 cells (1 hr exposure to 20 µM DCF-DA in HBSS, p<0.01, n=6). In both 
cell types, the addition of CCCP (10 µM) inhibits most ROS generation, strongly 
supporting a mitochondrial origin of this reactive oxygen (p<0.01, n=6).  
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To ensure that this difference in ROS generation was truly present, we employed 
an alternative method for ROS determination. In this case, the production of ROS by 
HeLa-20 and HeLa-80 cells was estimated by the oxidation of dihydroethidium which, 
upon peroxidatic oxidation by H2O2, is converted to ethidium. The ethidium then rapidly 
intercalates into DNA, thereby trapping the product of the reaction. We should note that 
in estimating the relative generation of ROS by these different cell lines, there were some 
technical problems. Introducing the fluorescent probe while the cells are in an 80% O2 
environment is impossible. Therefore, the cells must first be equilibrated with this 
atmosphere, the probe quickly added and the cells returned to hyperoxia. As a result, the 
initial pO2 will fluctuate. This was controlled by carrying out such incubations for 1, 2, 4, 
and 6 hr and expressing the ROS production per unit time. Using the dihydroethidium 
procedure, we were able to study ROS production over longer periods of time which 
allowed for equilibration of the cultured cells with the hyperoxic atmosphere. In this case, 
even greater differences in intracellular ROS generation were observed (Figure 20). As 
also shown in Figures 19 and 20, in both cell types, the addition of CCCP (10 µM) 
inhibited most ROS production under both 20% and 80% O2, strongly supporting a 
mitochondrial origin of this reactive oxygen. We should note that the results obtained 


















































Figure 20. Mitochondrial ROS generation in wild-type HeLa-20 and oxygen-tolerant 
HeLa-80 cells. ROS production was evaluated under both 20% O2 (A) and 80% O2 (B). 
(A): ROS production under 20% O2 was detected by the oxidation of the fluorescent 
probe dihydroethidium in the absence and presence of CCCP. These results are very 
similar to those obtained with DCF-DA (Figure 19), showing significantly lower ROS 
production by HeLa-80 vs. HeLa-20 cells (a 4 hr exposure to 100 µM dihydroethidium in 
complete culture medium, p<0.01, n=4).  Once again, addition of the uncoupler CCCP 
(10 µM) eliminated most of the ROS generation (p<0.05, n=4). (B): ROS production 
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under 80% O2 was tested by the oxidation of dihydroethidium in the absence and 
presence of CCCP. Under hyperoxia, ROS production increased 30-40% vs. normoxia in 
the wild-type HeLa-20 cells and was significantly higher in HeLa-20 vs. HeLa-80 cells (a 
4 hr exposure to 100 µM dihydroethidium in complete culture medium under 80% O2, 
p<0.01, n=4. In both cell types, the addition of CCCP (10 µM) inhibited most ROS 
generation (p<0.05, n=4), strongly supporting a mitochondrial origin of this reactive 
oxygen. 
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D. Additional evidence that oxygen tolerant HeLa-80 cells generate less ROS under both 
normoxia and hyperoxia  
If HeLa-80 cells avoid the cytotoxic and cytocidal effects of hyperoxia by virtue 
of diminished mitochondrial production of ROS, then this latter also should be reflected 
in other measures of intracellular ROS production. Two additional parameters generally 
support this idea. First, we measured total aconitase activity under normoxic and 
hyperoxic conditions. Given the susceptibility of aconitase to inactivation by ROS 
(Gardner et al., 1994), changes in the activity of this enzyme can be used as an indirect 
measure of intracellular ROS production. As shown in Figure 21, exposure of the wild-
type HeLa-20 cells to hyperoxia for 24 hr caused a ~70% decrease in total aconitase 
activity whereas the aconitase activity in oxygen-tolerant HeLa-80 cells was much less 
affected. Note that the activity of a reference enzyme, citrate synthase, was unchanged 
following similar exposure of either HeLa-20 or HeLa-80 cells to hyperoxia (data not 
shown). Second, we also measured the mitochondrial protein carbonyl content of the cells 
as an indication of the extent of protein oxidation. As shown in Figure 22, mitochondrial 
protein carbonyls increased significantly in HeLa-20 cells after 24 hr culture in 80% O2. 

































Figure 21. Wild-type HeLa-20, but not oxygen-tolerant HeLa-80 cells, show hyperoxia-
dependent inhibition of aconitase activity. Following 24 hr culture under 20% (filled 
bars) or 80% (blank bars) O2, aconitase activity was measured. Note the marked (~70%) 



































Figure 22. Wild-type HeLa-20, but not oxygen-tolerant HeLa-80 cells, show hyperoxia-
dependent increased mitochondrial protein carbonyl formation. Following 48 hr exposure 
to either 20% (filled bars) or 80% (blank bars) O2, mitochondrial protein carbonyl content 
was measured. Whereas HeLa-20 cells showed a significant increase in protein 
carbonyls, there was no change in HeLa-80 cells. Results represent means ± 1 SD of four 





E. Mitochondrial respiration inhibitors modulate ROS production by both HeLa-20 and 
HeLa-80 cells 
Although the above results (Figures 19 and 20) indicate that the majority of ROS 
being detected in both cell strains is almost certainly of mitochondrial origin, we 
conducted additional tests with three other inhibitors of mitochondrial respiration to 
further define the respiratory chain complex(es) which might be involved. For this, we 
used rotenone (a complex I inhibitor), thenoyltrifluoroacetone (TTFA) (a complex II 
inhibitor) and antimycin-A (a complex III inhibitor). Given that inhibition of complexes I 
and II will not completely prevent ROS production, we expected that the first two 
inhibitors would have lesser effect than did CCCP on ROS production. This appears to be 
the case; ROS production was reduced by a combination of these agents by 50% and 40% 






















Figure 23. Inhibitors of complexes I and II decrease ROS production in both HeLa-20 
and HeLa-80 cells as detected by DCF-DA oxidation under normoxia. ROS production 
was evaluated in the presence of rotenone (complex I inhibitor) and TTFA (complex II 
inhibitor) (p<0.01, n=5). 
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Interestingly, antimycin-A, a complex III inhibitor, greatly increased ROS 
production in both cell lines (Figure 24). This phenomenon has been observed previously 
(Zhang et al., 2001) and likely stems from an accumulation of the ubisemiquinone radical 
in the Q cycle of complex III. This also lends further support to the general view that 
complex III is the main site of ROS production under normal metabolic conditions 
(Finkel and Holbrook, 2000; Goijman and Stoppani, 1985). This involves the reduction 
of O2 to O2- by ubisemiquinone. In the absence of respiratory chain inhibition at complex 
III, the small steady state concentrations of ubisemiquinone are normally oxidized to 
ubiquinone by means of sequential reactions with cytochromes in the Q cycle, thereby 
preventing the accumulation of this potentially dangerous redox species. Overall, these 
results above further confirm that the generation of ROS is, in both cell types, 


























Figure 24. The mitochondrial inhibitor, antimycin A, increases ROS production in both 
HeLa-20 and HeLa-80 cells as detected by DCF-DA oxidation under normoxia. ROS 
production in the presence of antimycin A (complex III inhibitor) was markedly 
increased by the addition of antimycin A (p<0.05, n=4).   
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F. Summary of Part II 
Based on these results, we conclude that oxygen tolerant HeLa-80 cells do 
produce less ROS under both 20% O2 and 80% O2. The results of limited tests with 
inhibitors of various complexes within the mitochondrial electron transport chain support 
the view that these ROS mainly come from mitochondria. These observations raised the 
central question of the nature of the difference(s) in mitochondrial function responsible 
for the lessened ROS generation by HeLa-80 cells, a question addressed below in Part III.  
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Part III: Why Do the Mitochondria in HeLa-80 Cells Generate Less ROS? 
The diminished ROS production by HeLa-80 cells could potentially reflect either 
an overall suppression of mitochondrial metabolism or an enhanced efficiency of 
mitochondrial metabolism. In the former case (and assuming an equivalent demand for 
energy in both cell types), the less efficient mitochondrial metabolism would have to be 
compensated for by enhanced glucose consumption and production of lactic acid 
(reflecting increased need for glucose consumption and reduced oxidative carbohydrate 
metabolism by the mitochondria). However, in the event that mitochondrial metabolism 
were to be more tightly coupled (and, therefore, more efficient) both these parameters 
might be diminished. 
 
A. HeLa-80 cells are more metabolically efficient  
In an attempt to dissect the above possibilities, we compared wild-type HeLa-20 
and oxygen-tolerant HeLa-80 cell lines in terms of overall energy metabolism and 
oxygen consumption. As argued above, if HeLa-80 cells showed increased glucose 
consumption and lactate production it would imply lessened energy production through 
aerobic metabolism. On the other hand, decreased glucose consumption and lactate 
production would imply more efficient mitochondrial production of energy in HeLa-80 
cells (which our results support). As shown in Figures 25 and 26, it appears that both 
glucose consumption and lactate production are lower in the HeLa-80 cells under both 
normoxia and hyperoxia, supporting the idea that mitochondrial electron transport might 







































































Figure 25. Glucose consumption by HeLa cells were measured over a 24-hr period 
under both normoxic (20% O2) (A) and hyperoxic (80% O2) (B). Glucose 












































































Figure 26. Lactate production by HeLa cells were measured over a 24-hr period 
under both normoxic (20% O2) (A) and hyperoxic (80% O2) (B). Lactate production 
was decreased in oxygen-tolerant HeLa-80 cells under both conditions at 15 and 24 hr 
time points (p<0.05, n=3). 
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Measurements of glucose consumption required that we not use the usual glucose-
supplemented media but rather physiologic glucose (5 mM). Therefore, it is possible that 
this low glucose may have unanticipated effects on the normal rate of glucose 
metabolism. We should also note that this is by no means a complete metabolic survey; 
although in HeLa cells exogenous glucose is the main carbon source for glycolysis, 
glutamine and glutamate are important carbon fuels for oxidative metabolism (Donnelly 
and Scheffler, 1976). With regard to the basic energy supply in these cells we have 
conducted preliminary analyses of adenine nucleotide related intermediates 
(hypoxanthine, xanthine, inosine, inosine monophosphate, AMP, ADP and ATP) and find 
no substantial differences between HeLa-20 and HeLa-80 (although ρ° HeLa-20 cells do 
have a ~50% reduction in ATP as might be expected) (Table 4).  
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HeLa cells were cultured under 20% oxygen or 80% oxygen for 2 days. The metabolites were expressed as nmol per 
million cells and were calculated against standards. Absent (N/A) data mean the amount was too small to be calculated. There 
are no significant differences between HeLa-20 and HeLa-80 cells, although ρ° HeLa-20 cells have a ~50% reduction in ATP.  









Adenosine AMP ADP ATP IMP/ATP ADP/ATP 
20% O2 0.51 N/A N/A 1.24 0.22 0.16 1.59 4.70 0.26 0.34 HeLa-
20 80% O2 0.50 0.05 N/A 0.86 0.17 0.24 1.79 4.33 0.21 0.41 
20% O2 0.48 0.33 N/A 1.81 0.18 0.15 1.45 5.12 0.35 0.28 HeLa-
80 80% O2 0.55 0.09 0.24 2.24 0.23 0.19 1.68 6.41 0.34 0.26 
20% O2 0.23 0.28 0.31 1.20 N/A 0.35 1.14 2.45 0.49 0.47 ρ° 
HeLa-
20 80% O2 0.31 0.30 0.26 1.21 N/A 0.38 1.16 2.17 0.55 0.53 
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B. Cytochrome c oxidase (COX) activity is elevated in HeLa-80 cells 
In aggregate, the above results suggested an enhanced efficiency of electron 
transport in HeLa-80 cells. In view of the great reduction in ROS production caused by 
CCCP (Figure 19), we hypothesized that anything which would accelerate the movement 
of electrons down the electron transport chain would, by depleting the electron rich 
intermediates such as ubisemiquinone, decrease incidental one electron reduction of O2. 
Indeed, as shown in Figure 27, it appears that the activity of the terminal complex, COX, 
is substantially higher in HeLa-80 vs. HeLa-20 cells. Enhanced activity of this complex 
might well cause the aforementioned depletion of electron-rich intermediates. 
 
We might note that in the performance of these assays, there were several 
technical problems. First, preparation of cell lysates was not easy to control well and the 
enzyme activities can be affected by the cell preparation steps. There are several methods 
to release mitochondria from cells, such as homogenization, sonication and nitrogen 
cavitation. We have elected to use carefully timed sonication at a set energy for cell 
lysate preparation because it appeared the process was more reproduceable. Because 
variations in preparation of cell lysates or sonicates is a crucial variable, we used three 
different ways of expressing complex activities: cell protein concentrations, citrate 



























































































Figure 27. Cytochrome c oxidase activity in HeLa-20 and HeLa-80 cells expressed as 
activity per mg cell protein (A); COX activity per million cells (B); and as a ratio of COX 
activity vs. mitohondrial matrix enzyme, citrate synthase activity (C). Regardless of the 
way in which COX activity is calculated, it appears that HeLa-80 cells have ~2-fold 
higher activity than HeLa-20 cells (p<0.01, n=6). 
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C. There are no corresponding differences in the activities of complexes I-III in HeLa-20 
vs. HeLa-80 cells 
Measurements of the specific activities of the other complexes of the respiratory 
chain revealed, as shown in Figure 28, no differences in complex I (NADH reductase),  
complex II (succinate reductase) (Figure 29) or complex III (cytochrome c reductase) 
activities between the two cell lines (Figure 30). The above results which suggest that 
only COX activity is substantially increased in HeLa-80 cells whereas the activities of 
other components of the electron transport chain appear unaffected. This focussed our 



































Figure 28. Complex I (NADH reductase) activity in HeLa-20 and HeLa-80 cells 
expressed as activity per mg cell protein. Similar complex I activities were found in these 





































Figure 29. Complex II (succinate reductase) activity in HeLa-20 and HeLa-80 cells 
expressed as activity per mg cell protein. Equivalent complex II activities were found in 






































Figure 30. Complex III (cytochrome c reductase) activity in HeLa-20 and HeLa-80 cells 
expressed as activity per mg cell protein. Equivalent complex III activities were found in 
these two cell lines. 
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D. Preferential inhibition of cytochrome c oxidase activity in HeLa-80 cells abrogates 
their oxygen tolerance 
If HeLa-80 cells are protected against the cytostatic and cytotoxic effects of 
hyperoxia by increased COX activity and diminished ROS production, then blocking 
COX should restore susceptibility to hyperoxia. Because COX contains a unique type of 
heme (heme a), we investigated the effect of selective heme a deficiency on the tolerance 
of HeLa-80 cells to hyperoxia. We selectively reduced the synthesis of heme a using the 
ferrochelatase inhibitor, n-methyl protoporphyrin (NMP) (Atamna et al., 2001; Gamble et 
al., 2000). 
  
Cells were treated with 5 µM NMP for one week at which point COX activity was 
measured. As shown in Figure 31, significantly decreased COX activity was found. 
Importantly, we observed only slight decreases in catalase (heme b) and cytochrome c 
reductase (heme c) activities (~15% and ~10% reduction, respectively, in both cell lines). 
Decreased COX subunit II expression was found by western blotting in both HeLa-20 
and HeLa-80 cells (Figure 32). This result was not surprising inasmuch as failure to 
insert heme into the enzyme complex would be expected to lead to instability. It is also 
possible that deficiency of heme a per se might, by negative feedback, limit the synthesis 





































Figure 31. N-methyl protoporphyrin (NMP) preferentially blocks COX activity. Cells 
were cultured in the presence of 5 µM of NMP for 4 days, then COX activities were 
measured in all these cells.  Greatly decreased COX activities, almost to baseline, were 
found in both HeLa-20 and HeLa-80 cells treated with NMP (p<0.01, n=4). Similar 
results were obtained when data were normalized by the ratio of COX/Citrate synthase 












Figure 32. N-methyl protoporphyrin (NMP) preferentially decreases COX subunit II. 
Cells were cultured in the presence of 5 µM of NMP for 4 days, then COX subunit II 
protein expression was assessed by Western blotting. 
 
 
HeLa80     HeLa20     HeLa80+NMP    HeLa20+NMP 
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The NMP-induced deficiency in COX activity was, as expected, associated with 
ROS formation in HeLa-80 cells cultured in the presence of NMP in hyperoxia (Figure 
33). Most importantly, HeLa-80 cells cultured continually with 5 µM NMP lost 
resistance to hyperoxia, stopped growing and progressively died after 6 days exposure to 
80% O2 (Figure 34), resembling in this respect the behavior of the wild type HeLa-20 
cells. These results further support the general concept that the oxygen tolerance of 
HeLa-80 cells derives from tighter coupling of the electron transport chain due to higher 
COX activity, which depletes electron-rich intermediates within the electron transport 
























Figure 33. ROS production by HeLa-80 cells grown in the continuous presence of 5 µM 
N-methyl protoporphyrin (NMP) for different periods. Increased ROS formation was 


































Figure 34. COX suppression abrogates the oxygen tolerance of HeLa-80 cells. HeLa-80 
cells were grown in the continuous presence of 5 µM N-methyl protoporphyrin (NMP) 







E. HeLa-80 cells show a highly significant increase in ‘respiratory potential’   
If the increased COX activity in HeLa-80 cells has any physiologic significance, 
one might expect that this ‘reserve’ of COX activity might be apparent in the maximal O2 
consumption by these cells. As shown in Figure 35, steady-state O2 consumption was 
similar between these two cell lines. However, the rate was disproportionately increased 
in HeLa-80 cells exposed to CCCP compared to the increase observed in HeLa-20 cells 
(Figure 35). This result is in agreement with the recent suggestions (Villani et al., 1998; 
Villani and Attardi, 2000) that COX may actually be the rate limiting step in overall 
electron transport. To our knowledge, this is the first direct demonstration of this 
phenomenon. Our results also call into serious question earlier arguments that COX 
activity is present in vast excess and, therefore,  not limiting of respiration (Letellier et 
al., 1993). These earlier investigations involved the use of isolated mitochondria the 
respiratory activities of which which may not be representative of the intracellular 

































Figure 35. Oxygen consumption by HeLa-20 and HeLa-80 cells in the absence and 
presence of 20 µM CCCP. Note that addition of the uncoupler increases oxygen 
consumption in both lines but that the increase in very much greater in the HeLa-80 cells 
suggesting that these cells have enhanced ‘respiratory potential’. Measurements were 
made on cell suspensions (3-5 x 106 cells in 3 ml of complete culture medium) using a 
Yellow Springs Gilson Oxygraph. n=4 in all cases.   
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F. Summary of part III 
In an effort to explain the unusal oxygen tolerance and decreased ROS production 
of HeLa-80 cells, we hypothesized that an increase of COX activity might, like CCCP 
exposure, improve electron shuttling and accelerate proton pumping. Therefore, we 
measured COX activity in HeLa-20 and HeLa-80 cells. We found that COX activity was 
~2-fold higher in the oxygen-tolerant HeLa-80 cells. Other aspects of mitochondrial and 
general cell metabolism, including O2 consumption, appeared similar (although HeLa-80 
cells showed somewhat less glucose consumption and lactate production). Preferential 
blockade of COX activity by the ferrochelatase inhibitor, NMP, selectively diminished 
synthesis of heme a, decreased COX activity, increased ROS production and restored 
wild type oxygen sensitivity of HeLa-80 cells. In aggregate, this is strong evidence in 
favor of a critical role of hypertrophied COX activity in the unique ability of HeLa-80 
cells to survive in a hyperoxic environment. 
 
These findings, all favoring a central role for COX activity in tolerance to 
hyperoxia, prompted further investigations of the molecular basis of this increased 
activity as reported below in Part IV. 
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Part IV. Molecular Basis for the Increased COX Activity in HeLa-80 Cells 
Given the large number of subunits in complex IV (13; 3 encoded by the 
mitochondrial genome and 10 by the nuclear genome), the observed ~2-fold increase in 
COX activity was somewhat puzzling. That is, given that all these subunits must be 
independently synthesized, it was something of a mystery that all might be elevated 
simultaneously in HeLa-80 cells. Therefore, in an attempt to decipher the reasons for this, 
we measured the expression of protein and mRNA for selected components of COX.   
 
A. Subunit Vb of COX is over-expressed in HeLa-80 cells 
COX consists of 13 subunits variously encoded by mitochondrial and nuclear 
DNA as described above. The three larger subunits (I-III) are involved in the catalytic 
activity of COX and the smaller subunits are important in its regulation (Capaldi, 1990). 
For example, COX Vb, one of the smaller subunits of the cytochrome c oxidase complex, 
has been reported to be important in the regulation of overall COX activity (Sandona et 
al., 1995; Allen et al., 1995; Waterland et al., 1991). COX Va and Vb are differentially 
regulated by oxygen and heme (Allen et al., 1995). There are significant species and 
tissue differences in the relative expression of the nuclear-encoded subunits and these are 
also differentially regulated by environmental and developmental signals, which allows 
for metabolic adjustments to different energy demands (Capaldi, 1990; Vijayasarathy et 
al., 1998). In the following experiments, we examined four components of COX, two 
encoded by the mitochondrial genome (COX subunits I and II) and two encoded by the 
nuclear genome (COX subunits IV and Vb). We were careful to include Vb in these 
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analyses because, as discussed above, this has been invoked as an important regulator of 
overall COX activity. 
 
The most important result of these experiments is shown in Figure 36. COX Vb 
expression is increased >2-fold in HeLa-80 cells whereas we found no significant 
differences between the two cell lines in the levels of expression of other COX subunits 
(I, II, IV). In Western blot analyses, the amounts of protein in each sample must be 
identical; otherwise it is impossible to distinguish significant differences in the intensity 
of various immunoreactive bands. Therefore, we controlled for this in three separate 
ways: protein quantification, Ponceau S staining and β-actin control. In the final analyses, 

































Figure 36. Western blot analysis of COX subunit expression in HeLa-20 and HeLa-80 
cells. Protein samples were separated by SDS-PAGE, transferred to PVDF membranes 
and immunoblotted with goat anti-mouse IgG antibody. The blot was probed with β-actin 
as a loading control. COX Vb expression was increased >2-fold in HeLa-80 cells though 
other COX subunits (I, II & IV) were close to HeLa-20 cells. 
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Despite these results, we should mention that alternative mechanisms of control of 
COX activity exist which might not involve quantitative changes in COX subunit 
expression. These include phosphorylation/dephosphorylation (probably of subunit IV) 
(Steenaart and Shore, 1997) and allosteric inhibition by ATP (Kadenbach and Arnold, 
1999). Modifications which affect the former would certainly be missed by this analysis. 
The latter possibility is made unlikely (but not ruled out) by our observations that adenine 
nucleotide status in these two strains of cells is very similar. 
 
B. COX Vb mRNA levels are similar in HeLa-20 and HeLa-80 cells 
To further investigate the reasons for the distinct up-regulation of subunit Vb, we 
carried out real time RT-PCR to estimate the amounts of mRNA for this subunit. In 
extracts from both HeLa-20 and HeLa-80 cells, the CT values, which represent the 
threshold cycle, were nearly identical when referred to the total quantity of input mRNA. 
There was also no significant difference in COX Vb mRNA when expressed as a ratio to 





































Figure 37. Similar mRNA levels of COX Vb in HeLa-20 and HeLa-80 cells detected by 











C. Suppression of COX Vb expression via Small - interference RNA (SiRNA) in HeLa-
80 cells 
The above results lead to the tentative conclusion that the exaggerated COX 
activity of HeLa-80 cells derives from increased expression of COX Vb, probably 
through a post-transcriptional mechanism. To more directly test whether Vb expression 
levels critically affect overall COX activity, we employed siRNA transfection (an 
antisense strategy) to selectively decrease the expression of COX Vb in HeLa-80 cells. 
 
We designed and tested two different pairs of siRNA primers because some 
siRNAs may have multiple effects, may not work against the intended mRNA or may 
exhibit nonspecific primer annealing.  After 48 hr incubation at 37 °C, cells were 
processed for the evaluation of COX Vb protein production by Western blotting analysis 
and real-time RT-PCR. As shown in Figure 38A, Western blots revealed significantly 
decreased COX Vb in siRNA treated HeLa-80 cells and the extent of inhibition of 
expression was dependent on the dose of siRNA added. For these Western blotting 
analyses, β-actin was used as control and the results were calculated as the ratio of COX 
Vb/ β-actin (Figure 38B). Consistently, mRNA levels of COX Vb referred to β-actin 




























Figure 38. Significantly decreased COX Vb proteins were found in siRNA transfected 
HeLa-80 cells by Western blot. The results shown were obtained using two separate 

























Figure 39. Significantly decreased mRNA level for COX Vb was found in siRNA 
transfected HeLa-80 cells as detected by real time RT-PCR. Data were normalized for β-

















The above investigations employing siRNA are ongoing, with the ultimate goal of 
directly testing whether overall COX activity and, specifically, COX Vb expression, is 
critical for the ability of HeLa-80 cells to survive hyperoxic challenge. 
 
D. Summary of Part IV 
Although we still do not have a certain explanation for the elevated COX activity 
in HeLa-80 cells, the above results suggest that the over-expression of COX subunit Vb 
might be the cause of increased COX activity and therefore of oxygen tolerance. 
However, absolute proof is not yet available. The enhanced synthesis of Vb appears to 
arise from a post-transcriptional mechanism inasmuch as no significant differences were 
found in Vb mRNA levels using real time RT-PCR. Assuming that increased COX Vb 
synthesis might be critical for the elevated COX activity and oxygen tolerance in HeLa-
80 cells, we are now engaged in studies using siRNA to selectively down-regulate the 




Part V: Oxygen Tolerant Rats and HeLa-80 Cells: A Common Mechanism? 
A. Background 
A strain of oxygen tolerant rats, which survive indefinitely in 100% O2, was 
developed by our collaborator, Dr. John Repine, at the University of Colorado. This 
strain was derived from a single Sprague Dawley male rat which survived for an amazing 
144 hr in 100% O2 (almost 100% of wild type Sprague-Dawley rats are dead after 72 hr 
under these conditions). This unusual rat was bred to normal Sprague Dawley female 
rats, with the progeny being selected at 2 months of age for ability to survive 100% O2 
for 96 hr.  Development of this oxygen tolerant strain required 25 generations of 
breeding. Subsequent tests have revealed that exercise tolerance is 60% better than that of 
the wild type rats and the oxygen tolerant rats have increased longevity (with the males 
living ca. 25% longer than wild type). 
 
As was the case in the HeLa-80 cells, there were no differences in antioxidants 
(such as reduced glutathione (GSH) levels and the enzyme activities of manganese and 
copper/zinc superoxide dismutases, catalase, glucose-6-phosphate dehydrogenase, 
glutathione reductase and glutathione peroxidase between oxygen tolerant and control 
rats either under normoxia or following exposure to hyperoxia for 54 hr. However, 
hepatic mitochondria from the oxygen tolerant rats were found to generate significantly 
less ROS. Overall, these characteristics seemed to resemble those of the oxygen tolerant 
HeLa cells, prompting us to investigate the oxygen tolerance of fibroblasts derived from 
these unusual rats as well as their mitochondrial COX activity.   
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B. Pulmonary fibroblasts from oxygen tolerant rats are more sensitive to peroxide-
mediated killing 
As we had done with the oxygen tolerant HeLa cells, we tested the sensitivity of 
lung fibroblasts from the oxygen tolerant rats to killing by H2O2 and t-butyl 
hydroperoxide. Whereas the HeLa-20 and HeLa-80 cells exhibited no significant 
difference in killing by these oxidants, the fibroblasts from the oxygen tolerant rats were 
significantly more susceptible to such killing (Figure 40). In the course of these 
experiments, we inadvertently found that the oxygen tolerant rat fibroblasts reduce 
Alamar Blue at a rate <2-fold less than the wild type, suggesting some derangement in 























































Figure 40. Primary pulmonary fibroblasts cultured from oxygen tolerant rats are more 
sensitive to peroxide-mediated killing (A). Cell viability was estimated using reduction of 
Alamar blue. Note that fibroblasts derived from the oxygen tolerant rats have a 
significantly lower rate of dye reduction per µg protein compared to control cells from 
control rats (B) (p<0.05, n=4). 
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C. In the oxygen tolerant rats, mitochondrial COX activity is amplified  
These puzzling results notwithstanding, we proceeded to measure COX activity in 
the mitochondria of these rats to determine whether there might be differences in activity 
similar to those observed in the oxygen-tolerant HeLa cells. Very recent results suggest 
that the oxygen tolerant rats have an increase in COX activity of >2-fold, quite similar to 
the situation in the oxygen tolerant HeLa cells (Figure 41). This very exciting result 
suggests that there may be few and perhaps only one way to satisfactorily adjust to 
hyperoxia; i.e., limit the leak of electrons from the electron transport chain to oxygen. 







































Figure 41. Hepatic mitochondrial COX activity in control and oxygen tolerant rats 
expressed per mg protein. Oxygen tolerant rats have ~2-fold higher COX activity than 






In the hope of achieving a more fundamental understanding of the nature of 
oxygen toxicity, we have investigated the characteristics of a unique strain of HeLa cells 
selected for ability to survive and grow in 80% oxygen. There are two possible 
explanations for their oxygen tolerance: enhanced oxidant defenses or decreased ROS 
generation in a hyperoxic environment.  
 
Surprisingly, these cells do not appear to have increased anti-oxidant defenses 
(such as superoxide dismutases, catalase, reduced glutathione, glutathione reductase and 
glutathione peroxidase). Most directly, they are not more resistant to killing by 
exogenous oxidants such as hydrogen peroxide and t-butyl hydroperoxide.  
 
This directed our attention to possible differences in ROS production and in 
mitochondrial electron transport. We find a substantial difference in ROS generation 
under both normoxic and hyperoxic conditions. This appears to be related to a major 
change in mitochondrial electron transport. Whereas the oxygen tolerant cells have 
normal activities of complexes I-III, they show a distinct upregulation of the activity of 
complex IV, COX. 
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The consequences of this increased activity of COX include enhanced metabolic 
efficiency (i.e., somewhat decreased glucose consumption and lactate production) while 
the rate of oxygen consumption remains at near wild-type levels. However, the most 
important effect of upregulated COX activity would appear to be depletion of electron-
rich intermediates with the transport chain by ‘mass action’. The resultant decrease in 
tonic levels of ubisemiquinone (especially at complex III) leads to decreased incidental 
reduction of oxygen to superoxide, thereby explaining the very significant decrease in 


















Figure 42.  Schematic representation of our tentative conclusions. 
Oxygen tolerance derives from tighter coupling of the electron transport chain in 
HeLa-80 cells due to higher COX activity, which depletes electron-rich intermediates 
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The implication of the present findings is that perhaps the most effective way of 
dealing with the challenge of hyperoxia may be to decrease ROS production, rather than 
enhance anti-oxidant mechanisms. This tentative conclusion is further supported by 
preliminary observations in HeLa 99 cells (a strain separately selected for resistance to 
even higher levels of oxygen) and in a remarkable strain of oxygen tolerant Sprague-
Dawley rats derived by our collaborator, Dr. John Repine, in Denver, Colorado. In 
preliminary experiments, the HeLa 99 cells have similarly magnified activity of COX 
and, once again, apparently normal anti-oxidant defenses. In the case of the oxygen 
tolerant rats, early results indicate a similar increase in COX activity whereas, once again, 
antioxidant defenses appear to be completely normal.  
 
The overall implication of our observations is that effective adaptation of 
eukaryotes – from yeast to humans - may require upregulation of COX activity. We 
believe these results supply valuable additional information regarding the toxic effects of 
hyperoxia. We further believe that this information may be of use in devising strategies to 
manipulate mitochondrial electron transport and, thereby, limit the toxicity of oxygen.  
 
Below, we have tried to relate our observations to results derived from earlier 
investigations. 
 
The Cytostatic and Cytocidal Effects of Hyperoxia are Associated with Enhanced 
Intracellular ROS Production 
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As mentioned at the outset, the adverse effects of hyperoxia almost certainly 
derive from increased formation of ROS (Castro and Freeman, 2001; Chance et al., 1979; 
Gerschman et al., 1954). Chemically, it is unlikely that increments in the partial pressure 
of O2 will substantially change the potential for direct, chemical oxidation of biological 
molecules. Therefore, amplified cellular ROS production under hyperoxia most likely 
arises from increased reduction of O2 to O2- in metabolically-dependent reactions. 
However, the precise mechanism(s) involved in this process have not been fully 
elucidated. It is reasonable to suspect that excessive cellular ROS production at high O2 
tensions represents a by-product of mitochondrial electron transport, perhaps generated 
through the intermediacy of ubisemiquinone (Sanders et al., 1993). These ROS may then 
interact with transition metals to generate even more damaging species such as hydroxyl 
and metal-centered radicals. The increased ROS generation during exposure to hyperoxia 
can potentially overwhelm antioxidant defense mechanisms, even in the presence of 
exogenously administered antioxidants (Ho et al., 1998).  In support of the latter 
supposition, we have found that the survival of wild-type HeLa-20 cells is improved 
when the cells are cultured in the presence of added exogenous catalase (100 µg/ml) 
(results not shown). Assuming that the enzyme is not internalized by fluid phase 
endocytosis, this implies that a portion of hyperoxia-mediated cell damage may arise 
through the production of readily diffusable oxidants such as hydrogen peroxide which 
may reach toxic concentrations.   
 
The Origins of Hyperoxia-Mediated ROS Generation 
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A number of earlier investigations have indicted increased mitochondrial ROS 
production in hyperoxic cell damage. For example, in studies with yeast, it was found 
that manganese superoxide dismutase (MnSOD, the form of SOD targeted to the 
mitochondria) deficient organisms were readily killed by 100% O2 whereas wild type 
yeast was not affected by hyperoxia. However, if the MnSOD-deficient yeast were also 
ρ°, these organisms had a clear survival advantage under hyperoxic conditions (Guidot et 
al., 1993). These results imply that ROS generated under hyperoxic conditions probably 
have a mitochondrial origin and, further, that the mitochondria may be a target for this 
toxicity. In studies with mammals, increased ROS generation was found in sheep 
pulmonary microvascular endothelial cells exposed to 100% oxygen (Sanders et al., 
1993) and numerous reports show evidence of greatly increased oxidation of pulmonary 
components (protein carbonyl formation and oxidation of polyunsaturated fatty acids) in 
animals and humans exposed to hyperoxia (Freeman and Crapo, 1981; Freeman and 
Tanswell, 1985; Vozzelli et al., 2003). 
 
The Importance of Antioxidant Status in Oxygen Toxicity 
Pertinent to the results obtained with MnSOD-deficient yeast described above, 
homozygous MnSOD deficient mice have also been reported to be much more sensitive 
to oxygen toxicity (Asikainen et al., 2002). This and other observations on animals 
deficient in MnSOD are important inasmuch as they imply that this mitochondrial form 
of SOD is particularly important in anti-oxidant defense. A further implication is that 
damage to mitochondria under hyperoxic conditions may be an important factor in the 
damaging effects of high oxygen pressures. In this regard, it is worth noting that 
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endotoxin pre-treatment increases mitochondrial MnSOD activity and, simultaneously, 
improves the survival of rats exposed to hyperoxia (Guidot, 1996). MnSOD 
overexpression has also been shown to protect pulmonary epithelial cells from hyperoxic 
damage while overexpression of catalase was without effect (Ilizarov et al., 2001). This is 
in apparent conflict with our findings of a significant protection by exogenous catalase 
when wild-type HeLa-20 cells were grown under 80% oxygen. However, in our system, 
the amounts of catalase may have been far greater than those produced by the transgenic 
rats.  
  
Although not directly pertinent to damage caused by hyperoxia and related ROS 
production, heme oxygenase-1 (HO-1) overexpression has been reported to provide 
protection against oxidative stress (Lee et al., 1996). The mechanism(s) through which 
this might confer resistance to hyperoxia were not clear. In a possibly related observation, 
Otterbein et al. (1999) (Otterbein et al., 1999a) found that carbon monoxide (CO), a 
major by-product of heme degradation by HO-1, provided protection against hyperoxic 
lung damage in rats. These authors proposed that judicious CO administration might be 
therapeutically useful for the patients who need high oxygen therapy (Otterbein et al., 
1999b). We propose that these two observations might actually have the same root 
mechanism: both overexpression of HO-1 (through possible depletion of cellular heme 
and consequent depression of mitochondrial respiration) and CO exposure (which will 
also suppress mitochondrial function) might lead to diminished mitochondrial ROS 
production under hyperoxic conditions.  Overexpression of hexokinase II (HK II) was 
found to protect lung epithelial-like A549 cells against oxygen toxicity (Ahmad et al., 
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2002). This overexpression had the net effect of protecting mitochondria from oxidative 
assault (HKII is targeted for mitochondria) and these findings at least indirectly support 
our view that mitochondria may be the major target of oxygen toxicity (Ahmad et al., 
2002). 
  
Although these observations and a number of others suggest that antioxidants may 
lessen hyperoxic cell damage, the mechanism(s) involved in such protection are not clear 
and the extent of protection has typically been suboptimal. Thus, whereas modest 
protection against hyperoxia was reported to be afforded by MnSOD overexpression in 
rats by Ho et al. (1998), other investigators found little or no effect of similar 
overexpression in mice (Jackson et al., 1999). 
 
Oxygen Tolerant HeLa Cells Have Normal Antioxidant Defenses 
Surprisingly, antioxidant defenses (superoxide dismutases, catalase, reduced 
glutathione, glutathione reductase and glutathione peroxidase) do not differ between 
oxygen-tolerant HeLe-80 and wild-type HeLa-20 cells. Perhaps most directly, these two 
strains of HeLa cells are equally susceptible to the lethal effects of hydrogen peroxide 
and t-butyl hydroperoxide, clearly showing that defenses against such oxidants are not 
hypertrophied in the oxygen tolerant line. This contrasts with some earlier publications 
indicating that increased levels of glutathione (GSH), glutathione peroxidase (GPX) and 
glutathione reductase (GR) would diminish hyperoxic cell damage (Hoffman et al., 1980; 
Stevens and Autor, 1980; Rister and Baehner, 1976; Bhandari et al., 2000; Mockett et al., 
1999). It is possible (but unknown) that in the early stages of the 2-year period during 
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which HeLa-80 cells were being selected for oxygen tolerance some differences in 
antioxidant defenses appeared. However, the net result of this selection appears to have 
been a change in mitochondrial metabolism which restricts incidental ROS generation, 
thereby making adjustments in antioxidant defenses of nugatory import.  
 
This view is supported by other reports that elevated GSH did not protect human 
carcinoma cells (T47D-H3) against hyperoxia and that increased GPX activity afforded 
only minor protection (Bilodeau et al., 2002). These authors concluded that GPX 
overexpression was relatively ineffective because the damaging effects of hyperoxia also 
involved other types of free radicals which could not be controlled by GSH/GPX 
(Bilodeau et al., 2002).  
 
Mitochondrial Metabolism is the Focal Point of Hyperoxic Cell Injury 
We have explored the hypothesis that a conspiracy between elevated O2 and 
cellular respiration leads to the cytostatic and cytocidal effects of hyperoxia. More 
specifically, we have investigated the possibility that the intracellular production of ROS 
by mitochondria under conditions of elevated O2 pressures is the most important 
mechanism of damage. As tests of the importance of hyperoxia-mediated ROS 
production we employed three models: (i) respiration-deficient (ρo) HeLa cells lacking 
mtDNA and respiration, (ii) wild-type HeLa cells were cultured with CCCP (which 
uncouples mitochondrial metabolism and enhances respiration), and (iii) wild-type HeLa 
cells cultured in the presence of chloramphenicol (which inhibits mitochondrial inner 
membrane protein synthesis and suppresses respiration). Although these three strategies 
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change mitochondrial function in three different ways, they have one thing in common: 
all three maneuvers decrease mitochondrial ROS generation and increase tolerance to 
hyperoxia. As a result, we are able to conclude that interactions between respiring 
mitochondria and O2 are primarily responsible for hyperoxic cell damage.  
 
ρo cells require enriched DMEM medium supplemented with glucose, pyruvate 
and uridine. Pyruvate reacts readily with hydrogen peroxide (in an oxidative 
decarboxylation reaction) and this could conceivably improve cellular survival in 
hyperoxic conditions. For that reason, we cultured wild-type HeLa-20 cells in the same 
enriched medium as the ρo cells as well as conducting other experiments with non-ρo 
cells cultured with normal DMEM and F-10 media under both 20% and 80% oxygen. 
Regardless of the medium employed, after 5 days, wild-type HeLa-20 cells stopped 
growing and started dying under 80% oxygen whether in normal or pyruvate-
supplemented medium, clearly indicating that the improved survival and growth of ρo 
cells was a function of the lack of mitochondrial respiration.  
 
Cytochrome c Oxidase (COX) and ROS Production 
It has been shown that COX somehow modulates ROS production. A 20-30% 
reduction in cytochrome c oxidase has been associated with high levels of superoxide 
production in calcineurin transgenic mice and the excessive production of O2- evidently 
contributes to the development of cardiac failure induced by calcineurin adenovirus 
infection(Sayen et al., 2003). Another recent publication showed that COX inhibition was 
accompanied by increased ROS production in PC12 pheochromocytoma cells (Yuyama 
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et al., 2003). Further indication of the importance of differences in mitochondrial 
metabolism derives from studies of young versus old animals. Younger animals tend to 
have more active mitochondria but less electron ‘leak’. Interestingly, it has also been 
reported that COX activity may decline in both older people and patients with 
neurodegenerative diseases (Boffoli et al., 1994; Bowling and Beal, 1995; Mullerhocker, 
1989; Paradies et al., 1993; Rooyackers et al., 1996; Tian et al., 1998).  
 
Several recent reports – as well as our own experimental results – support the 
view that COX is the rate-limiting step of mitochondrial respiration (Villani and Attardi, 
1997; Villani et al., 1998; Villani and Attardi, 2000). In fact, it has been suggested that 
the relative COX capacity of mammalian cells is normally adjusted to a level only 
slightly higher than that required to support endogenous respiration (Villani and Attardi, 
2000). Further to this point, it has been reported that oxygen modulates COX function 
and hypoxia will (reversibly) decrease the Vmax of the enzyme (Chandel et al., 1996; 
Chandel et al., 1997; Semenza, 1999). Oxygen can also affect COX activity by changing 
the expression of specific subunit isoforms thereby modulating the overall catalytic 
properties of the enzyme (Allen et al., 1995; Burke and Poyton, 1998; Waterland et al., 
1991). 
 
The central importance of COX activity in cell function and survival has been 
further emphasized by studies in which this activity was inhibited. For example, 
inhibition of COX, with increased ROS, acted as an initiator of caspase-independent cell 
death (Yuyama et al., 2003). Changes in COX activity have even been invoked in the 
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mechanism of TNF-α-induced cell death. In this instance, cell death proceeds following 
suppression of the activity of respiratory enzymes, presumably COX (Jia et al., 1996). 
These observations raise an interesting parallel between the toxicities of TNF-α and 
hyperoxia, and suggest that the oxygen tolerant HeLa-80 cells may as well be resistant to 
the lethal effects of TNF-α. 
 
The Possibility that Increased COX Vb Expression Plays A Major Role in Higher COX 
Activity of HeLa-80 Cells 
It has been suggested that COXVb likely plays a critical role in proper COX 
assembly and/or regulation, and consequently in the maintenance of mitochondrial 
integrity and function (Beauchemin et al., 2001). In the present experiments, we have 
observed that the oxygen tolerant HeLa-80 cells have 2~3-fold higher COX Vb protein 
expression compared to wild-type HeLa-20 cells. COX Vb is an important regulatory 
subunit of this complex (13 subunit) enzyme.  Inhibition of COX Vb using siRNA causes 
a loss COX activity. The COX Vb sequence is the most conserved among the nuclear-
encoded subunits of COX. COX Vb contains three conserved cysteines in its C-terminus 
which are reported to bind zinc (Rizzuto et al., 1991). Interestingly, unlike other COX 
subunits, there are no tissue-specific transcripts for human COX Vb, and it appears that 
COX Vb may be a single and unique polypeptide existing in all tissues (Zeviani et al., 
1988). However, COXVb expression levels vary in different tissues. As might be 
expected, mitochondria from tissues with higher oxygen consumption such as the heart, 
kidney, and brain contain higher levels of COX Vb mRNA and protein than the liver 
(Vijayasarathy et al., 1998).  
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It has been reported that, in yeast, COX IV (the homologue of human COXVb) 
was essential for proper COX assembly (Dowhan et al., 1985). Recent publications 
suggested that COX Vb may also play a regulatory role in COX activity. For instance, 
Kadenbach reported that COX activity was inhibited by ATP at high intra-mitochondrial 
ATP/ADP ratios, which requires phosphorylation of COX Vb and COX II by protein 
kinase A (a cyclic adenosine monophosphate (cAMP)-dependent phosphorylation) 
(Bender and Kadenbach, 2000). This ATP inhibition was relieved by dephosphorylation 
of the COX enzyme by protein phosphatase 1 (Bender and Kadenbach, 2000). Thus, if 
COXVb is important to the overall COX activity, a >2-fold higher COX Vb expression 
might contribute to the 2-fold higher COX activity in oxygen tolerant HeLa-80 cells. 
  
Oxygen Tolerance in HeLa Cells and Rats: A Common Mechanism? 
We have carried out some preliminary investigations of an oxygen tolerant strain 
of rats bred from a founder which unexpectedly survived for 144 hr in 100% O2. We have 
found that isolated hepatic mitochondria from these animals show significantly decreased 
ROS production under normoxic conditions. Furthermore, the in vivo production of ROS 
upon exposure to 100% O2 is also less in the oxygen tolerant rats as judged by (I) the 
decrease in pulmonary aconitase activity (which probably reflects in situ ROS 
generation) and (ii) greatly decreased accumulation of nitrotyrosine in the lung following 
24 hr under 100% O2. These rats may have become tolerant to hyperoxia by the same 




As was the case with our HeLa-80 cells, there were no differences in antioxidants 
(such as reduced glutathione (GSH) levels and the enzyme activities of manganese and 
copper/zinc superoxide dismutases, catalase, glucose-6-phosphate dehydrogenase and 
glutathione peroxidase) between oxygen tolerant and control rats both under normoxia 
and following exposure to hyperoxia for 54 hr. This prompted us to conduct studies on 
the mitochondrial function of these rats. Because we had earlier found significantly 
higher COX activity in our oxygen-tolerant HeLa-80 cells, we measured COX activity in 
hepatic mitochondria from these animals. The results indicate that the tolerant animals 
have ~2.4-fold higher COX activity, very similar to that observed in our oxygen tolerant 
HeLa-80 cells.  
 
Interestingly (and unexpectedly), lung fibroblast cultures derived from these rats 
were found to be hypersensitive to killing by H2O2, measured by changes in the 
metabolically-dependent reduction of the fluorescent dye, Alamar Blue. In the course of 
these investigations, we inadvertently found that fibroblasts from the tolerant rat cells 
reduce this dye at a rate <50% of wild type fibroblasts when the reduction is expressed 
per mg protein.  As yet, we have no explanation for these unexpected findings which may 
reflect a global change in cellular redox poise associated with the oxygen tolerance of 
these unusual rats. These very exciting but preliminary observations suggest that in three 
instances (HeLa-80 and HeLa-99 cells which were separately selected and the oxygen 
tolerant rats) oxygen tolerance has been achieved through selection for cells and 
organisms the mitochondria of which generate substantially less ROS under hyperoxic 
conditions and by virtue of increased activity of COX.  
  154
The Possibility That Oxygen Tolerance Arises from Enhanced Anti-Apoptotic 
Mechanisms 
Some earlier reports do support our view that mitochondrial metabolism is 
crucially involved in hyperoxic cell damage. For example, Yoneda et al. (Yoneda et al., 
1995) found that ρo human fibroblasts were resistant to oxygen toxicity. Furthermore, 
O’Donovan et al. (O'Donovan et al., 2000) report that expression of glutathione reductase 
selectively targeted to mitochondria could attenuate the cytostatic effects of hyperoxia. 
However, we were troubled by a recent report from Budinger et al. (Budinger et al., 
2002) which concludes that hyperoxic cell death is independent of enhanced generation 
of ROS but dependent on expression of the pro-apoptotic proteins, Bax or Bak (and it 
antagonized by Bcl-XL). We cannot explain the discrepancy between our results and 
these particular investigations. However, we might point out that in this latter work, (i) 
the tests by which ρo status of the test cells were assured are not mentioned; (ii) the ρo 
cells were not cloned; (iii) surprisingly, there was no difference in ROS production 
between wild type and ρo cells under 20% oxygen and (iv) the necessary control of 
producing cybrids was not carried out, leaving open the possibility that ethidium-induced 
mutations affecting nuclear DNA might have influenced the oxygen tolerance of the ρo 
cells. Furthermore, we consider it unlikely that our present results are explained by 
significant variations in expression of pro- vs. anti-apoptotic proteins such as Bax and 
Bak versus Bcl-XL and Bcl-2, respectively. This is because we and others have reported 
that expression of the latter, in particular, is well known to provide significant protection 
against challenge with exogenous oxidants such as hydrogen peroxide (Zhao et al., 2001) 
whereas the HeLa-80 cells are normally sensitive to peroxide killing and the hyperoxia-
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resistant ρo HeLa-20 clones we have developed are, if anything, more susceptible to 
oxidant killing.  
 
Do Hyperoxia and Radiation Damage Cells through A Common Mechanism? 
Whereas there is a clear link between ROS production engendered by both 
ionizing radiation and hyperoxia, in one sense our observations run counter to a popular 
hypothesis, originally proposed by Gerschman (1954) (Gerschman et al., 1954) which 
states that the toxic action of both hyperoxia and X rays is based on a common 
mechanism involving the formation of oxidizing free radicals. Contrary to what might be 
predicted from this hypothesis, the oxygen-resistant HeLa-80 cells are not cross-resistant 
to gamma radiation. (Joenje et al., 1985). This implies that cellular properties conferring 
resistance to killing by hyperoxia do not necessarily contribute to cellular X-ray 
tolerance. In one way this makes sense: mitochondrial generation of ROS is important in 
hyperoxic cell damage whereas radiation damage is largely independent of this.  
 
Gerschmann also pointed out that X-irradiation in the presence of hyperoxia had 
an synergistic effect on cell damage (the so-called ‘oxygen enhancement ratio’) and that 
many other agents, such as sulfhydryl containing compounds could cross-protect against 
both  ionizing radiation and oxygen toxicity (Gerschman et al., 1954). Once again, these 
observations do not conflict with our current findings. There is no question that the 
generation of ROS by ionizing radiation is increased at higher partial pressures of 
oxygen, but this increase is passive and quite independent of mitochondrial ROS 
production. During irradiation, free radicals form throughout the cell. Furthermore, it 
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would appear that nuclear DNA is the major lethal target of ionizing radiation. In 
contrast, under hyperoxic conditions, the excessive ROS primarily come from 
mitochondria (and, perhaps, some a very small portion ROS may arise from microsomes 
and other organelles (Hamers, 1985). Therefore, the major hyperoxic damage to cells 
may involve targets other than nuclear DNA such as cell membranes, proteins and, 
perhaps, mitochondrial DNA.  
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SUMMARY AND CONCLUSIONS 
 
The aim of the research reported here was to explain the unusual oxygen tolerance 
of a strain of HeLa cells selected over a prolonged period of exposure to step-wise 
increases in the partial pressure of oxygen. A secondary aim was to achieve a better 
understanding of the nature of oxygen toxicity per se. 
 
Surprisingly, we find, as earlier reported by our collaborator Dr. Jeunje (Joenje et 
al., 1985) no significant differences in oxidant defense parameters nor in the ability of the 
oxygen tolerant HeLa cells to survive challenge with exogenous oxidants. Rather, the 
crucial difference appears to reside in the tendency of mitochondria to produce ROS 
under either normoxic or hyperoxic conditions. 
 
            Extensive testing of mitochondrial function in these cells led to the observation 
that the activity of cytochrome c oxidase – but not of the other components of the 
mitochondrial electron transport chain – is significantly increased. The net effect of this 
increase in COX activity appears to be depletion of electron-rich, ROS-generating, 
intermediates and, thus, diminished ROS production. Further to this point, we find a 
selective elevation of one sub-unit of COX, Vb, a known regulator of the overall stability 
and activity of this complex, 13 sub-unit enzyme. 
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Perhaps most excitingly, very recent observations of cells and tissues from an 
oxygen tolerant strain of rats suggest quite a similar picture: no changes in oxidant 
defense parameters or in tolerance to exogenous oxidants but (i) diminished 
mitochondrial ROS production and (ii) similarly exaggerated COX activity. 
 
Overall, these observations suggest that cells and intact animals may adapt 
genetically to hyperoxia through a similar mechanism: that of limiting mitochondrial 
ROS generation. These results suggest possible avenues for therapeutic interventions 
which, by modulating the synthesis of COX components – especially Vb – may enhance 
tolerance to hyperoxia and, quite possibly, other stressors commonly encountered in the 






The particular importance of COX Vb will be investigated using an antisense 
strategy, specifically, silencer-interference RNA (siRNA). Preliminary experiments 
indicate that this approach will work; siRNA transfection inhibited COX Vb selectively 
and COX activity was decreased proportionally to the dose of siRNA tranfected in HeLa-
80 cells. In further work, we shall: (i) Repeat the siRNA transfection and confirm the 
inhibitory effect by western blot and real time RT-PCR in both HeLa-20 and HeLa-80 
cells. (ii) Measure COX activity and ROS production in both siRNA transfected HeLa-20 
and HeLa-80 cells. (iii) Measure oxygen consumption in the absence and presence of 
CCCP in siRNA transfected HeLa cells. (iv) Determine the duration of the siRNA 
silencing effects and (v) Expose control and siRNA treated HeLa-80 cells to 80% oxygen 
to determine whether partial silencing of Vb diminishes oxygen tolerance.  
 
In additional investigations, we will also determine whether COX Vb is the 
critical factor for oxygen tolerance by selectively over-expressing this subunit in wild-
type HeLa-20 cells. After confirmation of increased Vb expression, the cells will be 
challenged with 80% O2 to determine whether this causes enhanced oxygen tolerance. 
Since COX Va is closely related to COX Vb (Allen et al., 1995; Waterland et al., 1991), 
additional investigations of COX Va expression by western blot and real time RT-PCR 
will be carried out. 
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Finally, if the above experiments suggest a critical role for COX Vb in the control 
of mitochondrial metabolism and ROS production, we will explore ways of 
therapeutically upregulating COX activity. Our first experiments will involve testing the 
effects of estrogen administration on cells and intact mice. It has been reported that 
physiologic concentrations of estrogen will increase the expression of COX subunits I-III 
(Bettini and Maggi, 1992; Chen et al., 1998; Morin et al., 2002; Vanitallie and Dannies, 
1988). Furthermore, a very recent report indicates that mitochondria from intact – but not 
ovarectomized – female rats generate substantially less ROS and, importantly, that ROS 
production by mitochondria from ovarectomized animals can be suppressed by the 
administration of estrogen (Borras et al., 2003). If this works as well in intact animals, we 
will determine whether the administration of estrogen (or other agents which may 
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LIST OF ABBREVIATIONS 
 
BSA     bovine serum albumin 
β-GAL     β-galactosidase   
cAMP      cyclic adenosine monophosphate  
CCCP      cyanide m-chlorophenylhydrazone 
COX     cytochrome c oxidase 
CT      cycle threshold  
DCF     2',7'-dichlorofluorescin 
DCFH-DA    dihydrodichlorofluorescein diacetate 
DCPIP     2,6-dichlorophenolindophenol 
DMEM    Dulbecco’s Modified Eagle’s Medium 
DNP     2,4-dinitrophenylhydrazine  
DTNB     dithionitrobenzoic acid  
DTT     dithiothreitol  
EB     ethidium bromide 
EDTA     ethylenediaminetetraacetic acid  
EGTA    ethylene glycol-bis (-aminoethyl ether) N,N,N',N'-tetraacetic acid  
FBS      fetal bovine serum 
GR      glutathione reductase 
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GSH      reduced glutathione 
GPX      glutathione peroxidase   
HBSS     Hank´s Balanced Salt Solution 
HeLa-20    wild-type HeLa cells 
HeLa-80    oxygen-tolerant HeLa cells 
HK II     hexokinase II  
H2O2        hydrogen peroxide 
HO·      hydroxyl radical 
HO-1     heme oxygenase-1 
MnSOD     manganese superoxide dismutase 
mtDNA    mitochondrial DNA 
NMP     N-methyl protoporphyrin  
O2     oxygen 
O2-     superoxide anion 
ρ° cells     cells lacking of mtDNA 
ρ° cybrids     ρ° cells with reconstituted mitochondria 
PBS     phosphate buffered saline 
PEG     Polyethylene glycol 2000  
PMSF      phenylmethylsulfonyl fluoride  
(RT)-PCR     reverse transcriptase-PCR 
ROS     reactive oxygen species 
siRNA     small interfering RNA  
SOD     superoxide dismutase 
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TCA     trichloroacetic acid  
Tris-HCl     tris-(hydroxymethyl)aminomethane hydrochloride  
TTFA     thenoyltrifluoroacetone 
Tween 20    polyoxyethylene-20-sorbitan monolaurate  
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